id	sid	tid	token	lemma	pos
dpc-221	1	1	dermatology	dermatology	NOUN
dpc-221	1	2	:	:	PUNCT
dpc-221	1	3	practical	practical	ADJ
dpc-221	1	4	and	and	CCONJ
dpc-221	1	5	conceptual	conceptual	ADJ
dpc-221	1	6	research	research	NOUN
dpc-221	1	7	|	|	ADV
dpc-221	1	8	dermatol	dermatol	ADJ
dpc-221	1	9	pract	pract	NOUN
dpc-221	1	10	concept	concept	NOUN
dpc-221	1	11	2017;7(2):6	2017;7(2):6	PROPN
dpc-221	1	12	31	31	NUM
dpc-221	1	13	dermatology	dermatology	NOUN
dpc-221	1	14	practical	practical	ADJ
dpc-221	1	15	&	&	CCONJ
dpc-221	1	16	conceptual	conceptual	ADJ
dpc-221	1	17	www.derm101.com	www.derm101.com	X
dpc-221	1	18	introduction	introduction	NOUN
dpc-221	1	19	vitiligo	vitiligo	NOUN
dpc-221	1	20	is	be	AUX
dpc-221	1	21	characterized	characterize	VERB
dpc-221	1	22	by	by	ADP
dpc-221	1	23	circumscribed	circumscribed	ADJ
dpc-221	1	24	depigmented	depigmented	ADJ
dpc-221	1	25	macules	macule	NOUN
dpc-221	1	26	and	and	CCONJ
dpc-221	1	27	patches	patch	NOUN
dpc-221	1	28	of	of	ADP
dpc-221	1	29	skin	skin	NOUN
dpc-221	1	30	.	.	PUNCT
dpc-221	2	1	it	it	PRON
dpc-221	2	2	is	be	AUX
dpc-221	2	3	a	a	DET
dpc-221	2	4	multifactorial	multifactorial	ADJ
dpc-221	2	5	disorder	disorder	NOUN
dpc-221	2	6	due	due	ADP
dpc-221	2	7	to	to	ADP
dpc-221	2	8	genetic	genetic	ADJ
dpc-221	2	9	and	and	CCONJ
dpc-221	2	10	environmental	environmental	ADJ
dpc-221	2	11	factors	factor	NOUN
dpc-221	2	12	.	.	PUNCT
dpc-221	3	1	vitiligo	vitiligo	PROPN
dpc-221	3	2	affects	affect	VERB
dpc-221	3	3	approximately	approximately	ADV
dpc-221	3	4	0.5	0.5	NUM
dpc-221	3	5	-	-	SYM
dpc-221	3	6	2	2	NUM
dpc-221	3	7	%	%	NOUN
dpc-221	3	8	of	of	ADP
dpc-221	3	9	the	the	DET
dpc-221	3	10	general	general	ADJ
dpc-221	3	11	population	population	NOUN
dpc-221	3	12	worldwide	worldwide	ADV
dpc-221	4	1	[	[	X
dpc-221	4	2	1	1	NUM
dpc-221	4	3	]	]	PUNCT
dpc-221	4	4	.	.	PUNCT
dpc-221	5	1	the	the	DET
dpc-221	5	2	disease	disease	NOUN
dpc-221	5	3	can	can	AUX
dpc-221	5	4	affect	affect	VERB
dpc-221	5	5	all	all	DET
dpc-221	5	6	age	age	NOUN
dpc-221	5	7	groups	group	NOUN
dpc-221	5	8	,	,	PUNCT
dpc-221	5	9	but	but	CCONJ
dpc-221	5	10	studies	study	NOUN
dpc-221	5	11	have	have	AUX
dpc-221	5	12	shown	show	VERB
dpc-221	5	13	that	that	SCONJ
dpc-221	5	14	most	most	ADJ
dpc-221	5	15	patients	patient	NOUN
dpc-221	5	16	seem	seem	VERB
dpc-221	5	17	to	to	PART
dpc-221	5	18	develop	develop	VERB
dpc-221	5	19	the	the	DET
dpc-221	5	20	disease	disease	NOUN
dpc-221	5	21	about	about	ADP
dpc-221	5	22	the	the	DET
dpc-221	5	23	age	age	NOUN
dpc-221	5	24	of	of	ADP
dpc-221	5	25	20	20	NUM
dpc-221	5	26	.	.	PUNCT
dpc-221	6	1	it	it	PRON
dpc-221	6	2	also	also	ADV
dpc-221	6	3	occurs	occur	VERB
dpc-221	6	4	more	more	ADV
dpc-221	6	5	often	often	ADV
dpc-221	6	6	in	in	ADP
dpc-221	6	7	individuals	individual	NOUN
dpc-221	6	8	with	with	ADP
dpc-221	6	9	dark	dark	ADJ
dpc-221	6	10	or	or	CCONJ
dpc-221	6	11	tanned	tanned	ADJ
dpc-221	6	12	skin	skin	NOUN
dpc-221	6	13	[	[	X
dpc-221	6	14	2	2	NUM
dpc-221	6	15	]	]	PUNCT
dpc-221	6	16	.	.	PUNCT
dpc-221	7	1	different	different	ADJ
dpc-221	7	2	theories	theory	NOUN
dpc-221	7	3	have	have	AUX
dpc-221	7	4	been	be	AUX
dpc-221	7	5	proposed	propose	VERB
dpc-221	7	6	for	for	ADP
dpc-221	7	7	the	the	DET
dpc-221	7	8	pathogenesis	pathogenesis	NOUN
dpc-221	7	9	of	of	ADP
dpc-221	7	10	vitiligo	vitiligo	NOUN
dpc-221	7	11	in	in	ADP
dpc-221	7	12	which	which	PRON
dpc-221	7	13	autoimmunity	autoimmunity	NOUN
dpc-221	7	14	in	in	ADP
dpc-221	7	15	genetically	genetically	ADV
dpc-221	7	16	susceptopical	susceptopical	ADJ
dpc-221	7	17	mycophenolate	mycophenolate	ADJ
dpc-221	7	18	mofetil	mofetil	NOUN
dpc-221	7	19	in	in	ADP
dpc-221	7	20	the	the	DET
dpc-221	7	21	treatment	treatment	NOUN
dpc-221	7	22	of	of	ADP
dpc-221	7	23	vitiligo	vitiligo	NOUN
dpc-221	7	24	:	:	PUNCT
dpc-221	7	25	a	a	DET
dpc-221	7	26	pilot	pilot	NOUN
dpc-221	7	27	study	study	NOUN
dpc-221	7	28	farhad	farhad	VERB
dpc-221	7	29	handjani1	handjani1	PROPN
dpc-221	7	30	,	,	PUNCT
dpc-221	7	31	2	2	NUM
dpc-221	7	32	,	,	PUNCT
dpc-221	7	33	shahin	shahin	PROPN
dpc-221	7	34	aghaei3	aghaei3	PROPN
dpc-221	7	35	,	,	PUNCT
dpc-221	7	36	iman	iman	NOUN
dpc-221	7	37	moezzi1	moezzi1	NOUN
dpc-221	7	38	,	,	PUNCT
dpc-221	7	39	2	2	NUM
dpc-221	7	40	,	,	PUNCT
dpc-221	7	41	nasrin	nasrin	PROPN
dpc-221	7	42	saki1	saki1	PROPN
dpc-221	7	43	,	,	PUNCT
dpc-221	7	44	2	2	NUM
dpc-221	7	45	1	1	NUM
dpc-221	7	46	molecular	molecular	ADJ
dpc-221	7	47	dermatology	dermatology	NOUN
dpc-221	7	48	research	research	NOUN
dpc-221	7	49	center	center	NOUN
dpc-221	7	50	,	,	PUNCT
dpc-221	7	51	shiraz	shiraz	PROPN
dpc-221	7	52	university	university	PROPN
dpc-221	7	53	of	of	ADP
dpc-221	7	54	medical	medical	ADJ
dpc-221	7	55	sciences	sciences	PROPN
dpc-221	7	56	,	,	PUNCT
dpc-221	7	57	shiraz	shiraz	PROPN
dpc-221	7	58	,	,	PUNCT
dpc-221	7	59	iran	iran	PROPN
dpc-221	7	60	2	2	NUM
dpc-221	7	61	department	department	NOUN
dpc-221	7	62	of	of	ADP
dpc-221	7	63	dermatology	dermatology	NOUN
dpc-221	7	64	,	,	PUNCT
dpc-221	7	65	school	school	NOUN
dpc-221	7	66	of	of	ADP
dpc-221	7	67	medicine	medicine	NOUN
dpc-221	7	68	,	,	PUNCT
dpc-221	7	69	shiraz	shiraz	PROPN
dpc-221	7	70	university	university	PROPN
dpc-221	7	71	of	of	ADP
dpc-221	7	72	medical	medical	ADJ
dpc-221	7	73	sciences	sciences	PROPN
dpc-221	7	74	,	,	PUNCT
dpc-221	7	75	shiraz	shiraz	PROPN
dpc-221	7	76	,	,	PUNCT
dpc-221	7	77	iran	iran	PROPN
dpc-221	7	78	3	3	NUM
dpc-221	7	79	dermatology	dermatology	NOUN
dpc-221	7	80	department	department	NOUN
dpc-221	7	81	,	,	PUNCT
dpc-221	7	82	school	school	NOUN
dpc-221	7	83	of	of	ADP
dpc-221	7	84	medicine	medicine	NOUN
dpc-221	7	85	,	,	PUNCT
dpc-221	7	86	iran	iran	PROPN
dpc-221	7	87	university	university	PROPN
dpc-221	7	88	of	of	ADP
dpc-221	7	89	medical	medical	ADJ
dpc-221	7	90	sciences	sciences	PROPN
dpc-221	7	91	,	,	PUNCT
dpc-221	7	92	tehran	tehran	PROPN
dpc-221	7	93	,	,	PUNCT
dpc-221	7	94	iran	iran	PROPN
dpc-221	7	95	key	key	ADJ
dpc-221	7	96	words	word	NOUN
dpc-221	7	97	:	:	PUNCT
dpc-221	7	98	vitiligo	vitiligo	VERB
dpc-221	7	99	,	,	PUNCT
dpc-221	7	100	mycophenolate	mycophenolate	PROPN
dpc-221	7	101	mofetil	mofetil	PROPN
dpc-221	7	102	,	,	PUNCT
dpc-221	7	103	repigmentation	repigmentation	NOUN
dpc-221	7	104	citation	citation	NOUN
dpc-221	7	105	:	:	PUNCT
dpc-221	8	1	handjani	handjani	PROPN
dpc-221	8	2	f	f	X
dpc-221	8	3	,	,	PUNCT
dpc-221	8	4	aghaei	aghaei	PROPN
dpc-221	8	5	s	s	PROPN
dpc-221	8	6	,	,	PUNCT
dpc-221	8	7	moezzi	moezzi	VERB
dpc-221	8	8	i	i	PRON
dpc-221	8	9	,	,	PUNCT
dpc-221	8	10	saki	saki	PROPN
dpc-221	8	11	n.	n.	PROPN
dpc-221	8	12	topical	topical	ADJ
dpc-221	8	13	mycophenolate	mycophenolate	VERB
dpc-221	8	14	mofetil	mofetil	NOUN
dpc-221	8	15	in	in	ADP
dpc-221	8	16	the	the	DET
dpc-221	8	17	treatment	treatment	NOUN
dpc-221	8	18	of	of	ADP
dpc-221	8	19	vitiligo	vitiligo	NOUN
dpc-221	8	20	:	:	PUNCT
dpc-221	8	21	a	a	DET
dpc-221	8	22	pilot	pilot	NOUN
dpc-221	8	23	study	study	NOUN
dpc-221	8	24	.	.	PUNCT
dpc-221	9	1	dermatol	dermatol	NOUN
dpc-221	9	2	pract	pract	PROPN
dpc-221	9	3	concept	concept	NOUN
dpc-221	9	4	.	.	PUNCT
dpc-221	10	1	2017;7(2):6	2017;7(2):6	PROPN
dpc-221	10	2	.	.	PUNCT
dpc-221	11	1	doi	doi	PROPN
dpc-221	11	2	:	:	PUNCT
dpc-221	11	3	https://doi.org/10.5826/dpc.0702a06	https://doi.org/10.5826/dpc.0702a06	PROPN
dpc-221	11	4	received	receive	VERB
dpc-221	11	5	:	:	PUNCT
dpc-221	11	6	october	october	PROPN
dpc-221	11	7	10	10	NUM
dpc-221	11	8	,	,	PUNCT
dpc-221	11	9	2016	2016	NUM
dpc-221	11	10	;	;	PUNCT
dpc-221	11	11	accepted	accept	VERB
dpc-221	11	12	:	:	PUNCT
dpc-221	11	13	december	december	PROPN
dpc-221	11	14	23	23	NUM
dpc-221	11	15	,	,	PUNCT
dpc-221	11	16	2016	2016	NUM
dpc-221	11	17	;	;	PUNCT
dpc-221	11	18	published	publish	VERB
dpc-221	11	19	:	:	PUNCT
dpc-221	11	20	april	april	PROPN
dpc-221	11	21	30	30	NUM
dpc-221	11	22	,	,	PUNCT
dpc-221	11	23	2017	2017	NUM
dpc-221	11	24	copyright	copyright	NOUN
dpc-221	11	25	:	:	PUNCT
dpc-221	11	26	©	©	PROPN
dpc-221	11	27	2017	2017	NUM
dpc-221	11	28	handjani	handjani	X
dpc-221	11	29	et	et	PROPN
dpc-221	11	30	al	al	PROPN
dpc-221	11	31	.	.	PUNCT
dpc-221	12	1	this	this	PRON
dpc-221	12	2	is	be	AUX
dpc-221	12	3	an	an	DET
dpc-221	12	4	open	open	ADJ
dpc-221	12	5	-	-	PUNCT
dpc-221	12	6	access	access	NOUN
dpc-221	12	7	article	article	NOUN
dpc-221	12	8	distributed	distribute	VERB
dpc-221	12	9	under	under	ADP
dpc-221	12	10	the	the	DET
dpc-221	12	11	terms	term	NOUN
dpc-221	12	12	of	of	ADP
dpc-221	12	13	the	the	DET
dpc-221	12	14	creative	creative	ADJ
dpc-221	12	15	commons	common	NOUN
dpc-221	12	16	attribution	attribution	NOUN
dpc-221	12	17	license	license	NOUN
dpc-221	12	18	,	,	PUNCT
dpc-221	12	19	which	which	PRON
dpc-221	12	20	permits	permit	VERB
dpc-221	12	21	unrestricted	unrestricted	ADJ
dpc-221	12	22	use	use	NOUN
dpc-221	12	23	,	,	PUNCT
dpc-221	12	24	distribution	distribution	NOUN
dpc-221	12	25	,	,	PUNCT
dpc-221	12	26	and	and	CCONJ
dpc-221	12	27	reproduction	reproduction	NOUN
dpc-221	12	28	in	in	ADP
dpc-221	12	29	any	any	DET
dpc-221	12	30	medium	medium	NOUN
dpc-221	12	31	,	,	PUNCT
dpc-221	12	32	provided	provide	VERB
dpc-221	12	33	the	the	DET
dpc-221	12	34	original	original	ADJ
dpc-221	12	35	author	author	NOUN
dpc-221	12	36	and	and	CCONJ
dpc-221	12	37	source	source	NOUN
dpc-221	12	38	are	be	AUX
dpc-221	12	39	credited	credit	VERB
dpc-221	12	40	.	.	PUNCT
dpc-221	13	1	funding	funding	NOUN
dpc-221	13	2	:	:	PUNCT
dpc-221	13	3	none	none	NOUN
dpc-221	13	4	.	.	PUNCT
dpc-221	14	1	competing	compete	VERB
dpc-221	14	2	interests	interest	NOUN
dpc-221	14	3	:	:	PUNCT
dpc-221	14	4	the	the	DET
dpc-221	14	5	authors	author	NOUN
dpc-221	14	6	have	have	VERB
dpc-221	14	7	no	no	DET
dpc-221	14	8	conflicts	conflict	NOUN
dpc-221	14	9	of	of	ADP
dpc-221	14	10	interest	interest	NOUN
dpc-221	14	11	to	to	PART
dpc-221	14	12	disclose	disclose	VERB
dpc-221	14	13	.	.	PUNCT
dpc-221	15	1	all	all	DET
dpc-221	15	2	authors	author	NOUN
dpc-221	15	3	have	have	AUX
dpc-221	15	4	contributed	contribute	VERB
dpc-221	15	5	significantly	significantly	ADV
dpc-221	15	6	to	to	ADP
dpc-221	15	7	this	this	DET
dpc-221	15	8	publication	publication	NOUN
dpc-221	15	9	.	.	PUNCT
dpc-221	16	1	corresponding	correspond	VERB
dpc-221	16	2	author	author	NOUN
dpc-221	16	3	:	:	PUNCT
dpc-221	16	4	nasrin	nasrin	PROPN
dpc-221	16	5	saki	saki	PROPN
dpc-221	16	6	,	,	PUNCT
dpc-221	16	7	md	md	PROPN
dpc-221	16	8	,	,	PUNCT
dpc-221	16	9	molecular	molecular	ADJ
dpc-221	16	10	dermatology	dermatology	NOUN
dpc-221	16	11	research	research	NOUN
dpc-221	16	12	center	center	NOUN
dpc-221	16	13	,	,	PUNCT
dpc-221	16	14	shiraz	shiraz	PROPN
dpc-221	16	15	university	university	PROPN
dpc-221	16	16	of	of	ADP
dpc-221	16	17	medical	medical	ADJ
dpc-221	16	18	sciences	sciences	PROPN
dpc-221	16	19	,	,	PUNCT
dpc-221	16	20	shiraz	shiraz	PROPN
dpc-221	16	21	,	,	PUNCT
dpc-221	16	22	iran	iran	PROPN
dpc-221	16	23	7134844119	7134844119	NUM
dpc-221	16	24	.	.	PUNCT
dpc-221	17	1	email	email	NOUN
dpc-221	17	2	:	:	PUNCT
dpc-221	17	3	nasrinsa85@yahoo.com	nasrinsa85@yahoo.com	X
dpc-221	17	4	background	background	NOUN
dpc-221	17	5	:	:	PUNCT
dpc-221	17	6	vitiligo	vitiligo	VERB
dpc-221	17	7	is	be	AUX
dpc-221	17	8	a	a	DET
dpc-221	17	9	multifactorial	multifactorial	ADJ
dpc-221	17	10	disease	disease	NOUN
dpc-221	17	11	that	that	PRON
dpc-221	17	12	is	be	AUX
dpc-221	17	13	characterized	characterize	VERB
dpc-221	17	14	by	by	ADP
dpc-221	17	15	circumscribed	circumscribed	ADJ
dpc-221	17	16	depigmented	depigmented	ADJ
dpc-221	17	17	macules	macule	NOUN
dpc-221	17	18	and	and	CCONJ
dpc-221	17	19	patches	patch	NOUN
dpc-221	17	20	.	.	PUNCT
dpc-221	18	1	autoimmune	autoimmune	ADJ
dpc-221	18	2	reactions	reaction	NOUN
dpc-221	18	3	may	may	AUX
dpc-221	18	4	play	play	VERB
dpc-221	18	5	an	an	DET
dpc-221	18	6	important	important	ADJ
dpc-221	18	7	role	role	NOUN
dpc-221	18	8	in	in	ADP
dpc-221	18	9	the	the	DET
dpc-221	18	10	pathogenesis	pathogenesis	NOUN
dpc-221	18	11	of	of	ADP
dpc-221	18	12	the	the	DET
dpc-221	18	13	disease	disease	NOUN
dpc-221	18	14	.	.	PUNCT
dpc-221	19	1	mycophenolate	mycophenolate	PROPN
dpc-221	19	2	mofetil	mofetil	PROPN
dpc-221	19	3	is	be	AUX
dpc-221	19	4	a	a	DET
dpc-221	19	5	drug	drug	NOUN
dpc-221	19	6	that	that	PRON
dpc-221	19	7	inhibits	inhibit	VERB
dpc-221	19	8	dna	dna	ADJ
dpc-221	19	9	synthesis	synthesis	NOUN
dpc-221	19	10	in	in	ADP
dpc-221	19	11	lymphocytes	lymphocyte	NOUN
dpc-221	19	12	and	and	CCONJ
dpc-221	19	13	has	have	AUX
dpc-221	19	14	been	be	AUX
dpc-221	19	15	used	use	VERB
dpc-221	19	16	in	in	ADP
dpc-221	19	17	autoimmune	autoimmune	ADJ
dpc-221	19	18	diseases	disease	NOUN
dpc-221	19	19	such	such	ADJ
dpc-221	19	20	as	as	ADP
dpc-221	19	21	immunobullous	immunobullous	ADJ
dpc-221	19	22	skin	skin	NOUN
dpc-221	19	23	diseases	disease	NOUN
dpc-221	19	24	,	,	PUNCT
dpc-221	19	25	lupus	lupus	NOUN
dpc-221	19	26	erythematosus	erythematosus	NOUN
dpc-221	19	27	,	,	PUNCT
dpc-221	19	28	and	and	CCONJ
dpc-221	19	29	autoimmune	autoimmune	ADJ
dpc-221	19	30	hepatitis	hepatitis	NOUN
dpc-221	19	31	.	.	PUNCT
dpc-221	20	1	objectives	objective	NOUN
dpc-221	20	2	:	:	PUNCT
dpc-221	20	3	the	the	DET
dpc-221	20	4	objective	objective	NOUN
dpc-221	20	5	of	of	ADP
dpc-221	20	6	this	this	DET
dpc-221	20	7	study	study	NOUN
dpc-221	20	8	was	be	AUX
dpc-221	20	9	to	to	PART
dpc-221	20	10	show	show	VERB
dpc-221	20	11	the	the	DET
dpc-221	20	12	efficacy	efficacy	NOUN
dpc-221	20	13	of	of	ADP
dpc-221	20	14	topical	topical	ADJ
dpc-221	20	15	mycophenolate	mycophenolate	NOUN
dpc-221	20	16	mofetil	mofetil	NOUN
dpc-221	20	17	in	in	ADP
dpc-221	20	18	the	the	DET
dpc-221	20	19	treatment	treatment	NOUN
dpc-221	20	20	of	of	ADP
dpc-221	20	21	vitiligo	vitiligo	NOUN
dpc-221	20	22	.	.	PUNCT
dpc-221	21	1	methods	method	NOUN
dpc-221	21	2	:	:	PUNCT
dpc-221	21	3	thirty	thirty	NUM
dpc-221	21	4	patients	patient	NOUN
dpc-221	21	5	with	with	ADP
dpc-221	21	6	limited	limited	ADJ
dpc-221	21	7	vitiligo	vitiligo	NOUN
dpc-221	21	8	were	be	AUX
dpc-221	21	9	enrolled	enrol	VERB
dpc-221	21	10	in	in	ADP
dpc-221	21	11	this	this	DET
dpc-221	21	12	study	study	NOUN
dpc-221	21	13	.	.	PUNCT
dpc-221	22	1	the	the	DET
dpc-221	22	2	patients	patient	NOUN
dpc-221	22	3	applied	apply	VERB
dpc-221	22	4	a	a	DET
dpc-221	22	5	topical	topical	ADJ
dpc-221	22	6	preparation	preparation	NOUN
dpc-221	22	7	of	of	ADP
dpc-221	22	8	mycophenolate	mycophenolate	ADJ
dpc-221	22	9	mofetil	mofetil	NOUN
dpc-221	22	10	15	15	NUM
dpc-221	22	11	%	%	NOUN
dpc-221	22	12	twice	twice	ADV
dpc-221	22	13	daily	daily	ADV
dpc-221	22	14	for	for	ADP
dpc-221	22	15	three	three	NUM
dpc-221	22	16	months	month	NOUN
dpc-221	22	17	and	and	CCONJ
dpc-221	22	18	at	at	ADP
dpc-221	22	19	the	the	DET
dpc-221	22	20	end	end	NOUN
dpc-221	22	21	of	of	ADP
dpc-221	22	22	every	every	DET
dpc-221	22	23	month	month	NOUN
dpc-221	22	24	,	,	PUNCT
dpc-221	22	25	repigmentation	repigmentation	NOUN
dpc-221	22	26	was	be	AUX
dpc-221	22	27	assessed	assess	VERB
dpc-221	22	28	using	use	VERB
dpc-221	22	29	the	the	DET
dpc-221	22	30	vitiligo	vitiligo	NOUN
dpc-221	22	31	area	area	NOUN
dpc-221	22	32	scoring	scoring	NOUN
dpc-221	22	33	index	index	NOUN
dpc-221	22	34	(	(	PUNCT
dpc-221	22	35	vasi	vasi	PROPN
dpc-221	22	36	)	)	PUNCT
dpc-221	22	37	.	.	PUNCT
dpc-221	23	1	results	result	NOUN
dpc-221	23	2	:	:	PUNCT
dpc-221	23	3	at	at	ADP
dpc-221	23	4	the	the	DET
dpc-221	23	5	end	end	NOUN
dpc-221	23	6	of	of	ADP
dpc-221	23	7	the	the	DET
dpc-221	23	8	third	third	ADJ
dpc-221	23	9	month	month	NOUN
dpc-221	23	10	,	,	PUNCT
dpc-221	23	11	36.6	36.6	NUM
dpc-221	23	12	%	%	NOUN
dpc-221	23	13	(	(	PUNCT
dpc-221	23	14	n=11	n=11	NOUN
dpc-221	23	15	)	)	PUNCT
dpc-221	23	16	of	of	ADP
dpc-221	23	17	the	the	DET
dpc-221	23	18	patients	patient	NOUN
dpc-221	23	19	showed	show	VERB
dpc-221	23	20	about	about	ADP
dpc-221	23	21	25	25	NUM
dpc-221	23	22	%	%	NOUN
dpc-221	23	23	repigmentation	repigmentation	NOUN
dpc-221	23	24	of	of	ADP
dpc-221	23	25	the	the	DET
dpc-221	23	26	lesions	lesion	NOUN
dpc-221	23	27	.	.	PUNCT
dpc-221	24	1	no	no	DET
dpc-221	24	2	side	side	NOUN
dpc-221	24	3	effects	effect	NOUN
dpc-221	24	4	were	be	AUX
dpc-221	24	5	observed	observe	VERB
dpc-221	24	6	throughout	throughout	ADP
dpc-221	24	7	the	the	DET
dpc-221	24	8	study	study	NOUN
dpc-221	24	9	.	.	PUNCT
dpc-221	25	1	conclusion	conclusion	NOUN
dpc-221	25	2	:	:	PUNCT
dpc-221	25	3	this	this	DET
dpc-221	25	4	study	study	NOUN
dpc-221	25	5	showed	show	VERB
dpc-221	25	6	that	that	SCONJ
dpc-221	25	7	topical	topical	ADJ
dpc-221	25	8	mycophenolate	mycophenolate	NOUN
dpc-221	25	9	mofetil	mofetil	NOUN
dpc-221	25	10	can	can	AUX
dpc-221	25	11	be	be	AUX
dpc-221	25	12	somewhat	somewhat	ADV
dpc-221	25	13	effective	effective	ADJ
dpc-221	25	14	in	in	ADP
dpc-221	25	15	the	the	DET
dpc-221	25	16	treatment	treatment	NOUN
dpc-221	25	17	of	of	ADP
dpc-221	25	18	vitiligo	vitiligo	NOUN
dpc-221	25	19	;	;	PUNCT
dpc-221	25	20	however	however	ADV
dpc-221	25	21	,	,	PUNCT
dpc-221	25	22	it	it	PRON
dpc-221	25	23	seems	seem	VERB
dpc-221	25	24	to	to	PART
dpc-221	25	25	be	be	AUX
dpc-221	25	26	inferior	inferior	ADJ
dpc-221	25	27	to	to	PART
dpc-221	25	28	potent	potent	VERB
dpc-221	25	29	topical	topical	ADJ
dpc-221	25	30	steroids	steroid	NOUN
dpc-221	25	31	in	in	ADP
dpc-221	25	32	inducing	induce	VERB
dpc-221	25	33	repigmentation	repigmentation	NOUN
dpc-221	25	34	.	.	PUNCT
dpc-221	26	1	abstract	abstract	ADJ
dpc-221	26	2	mailto:nasrinsa85@yahoo.com	mailto:nasrinsa85@yahoo.com	PROPN
dpc-221	26	3	32	32	NUM
dpc-221	26	4	research	research	NOUN
dpc-221	26	5	|	|	ADV
dpc-221	26	6	dermatol	dermatol	NOUN
dpc-221	26	7	pract	pract	NOUN
dpc-221	26	8	concept	concept	NOUN
dpc-221	26	9	2017;7(2):6	2017;7(2):6	PROPN
dpc-221	26	10	medical	medical	ADJ
dpc-221	26	11	sciences	science	NOUN
dpc-221	26	12	and	and	CCONJ
dpc-221	27	1	all	all	DET
dpc-221	27	2	patients	patient	NOUN
dpc-221	27	3	signed	sign	VERB
dpc-221	27	4	the	the	DET
dpc-221	27	5	informed	informed	ADJ
dpc-221	27	6	consent	consent	NOUN
dpc-221	27	7	form	form	NOUN
dpc-221	27	8	.	.	PUNCT
dpc-221	28	1	statistical	statistical	ADJ
dpc-221	28	2	analysis	analysis	NOUN
dpc-221	28	3	was	be	AUX
dpc-221	28	4	performed	perform	VERB
dpc-221	28	5	with	with	ADP
dpc-221	28	6	the	the	DET
dpc-221	28	7	spss	spss	PROPN
dpc-221	28	8	19.0	19.0	NUM
dpc-221	28	9	statistical	statistical	ADJ
dpc-221	28	10	package	package	NOUN
dpc-221	28	11	(	(	PUNCT
dpc-221	28	12	spss	spss	PROPN
dpc-221	28	13	inc	inc	PROPN
dpc-221	28	14	.	.	PROPN
dpc-221	28	15	,	,	PUNCT
dpc-221	28	16	chicago	chicago	PROPN
dpc-221	28	17	,	,	PUNCT
dpc-221	28	18	il	il	PROPN
dpc-221	28	19	,	,	PUNCT
dpc-221	28	20	usa	usa	PROPN
dpc-221	28	21	)	)	PUNCT
dpc-221	28	22	,	,	PUNCT
dpc-221	28	23	using	use	VERB
dpc-221	28	24	paired	pair	VERB
dpc-221	28	25	t	t	NOUN
dpc-221	28	26	-	-	PUNCT
dpc-221	28	27	test	test	NOUN
dpc-221	28	28	and	and	CCONJ
dpc-221	28	29	descriptive	descriptive	ADJ
dpc-221	28	30	methods	method	NOUN
dpc-221	28	31	.	.	PUNCT
dpc-221	29	1	the	the	DET
dpc-221	29	2	criterion	criterion	NOUN
dpc-221	29	3	for	for	ADP
dpc-221	29	4	statistical	statistical	ADJ
dpc-221	29	5	significance	significance	NOUN
dpc-221	29	6	was	be	AUX
dpc-221	29	7	at	at	ADP
dpc-221	29	8	a	a	DET
dpc-221	29	9	=	=	NOUN
dpc-221	29	10	0.05	0.05	NUM
dpc-221	29	11	.	.	PUNCT
dpc-221	30	1	results	result	VERB
dpc-221	30	2	thirty	thirty	NUM
dpc-221	30	3	patients	patient	NOUN
dpc-221	30	4	were	be	AUX
dpc-221	30	5	included	include	VERB
dpc-221	30	6	in	in	ADP
dpc-221	30	7	this	this	DET
dpc-221	30	8	study	study	NOUN
dpc-221	30	9	with	with	ADP
dpc-221	30	10	a	a	DET
dpc-221	30	11	mean	mean	ADJ
dpc-221	30	12	age	age	NOUN
dpc-221	30	13	of	of	ADP
dpc-221	30	14	32.8	32.8	NUM
dpc-221	30	15	years	year	NOUN
dpc-221	30	16	(	(	PUNCT
dpc-221	30	17	with	with	ADP
dpc-221	30	18	an	an	DET
dpc-221	30	19	age	age	NOUN
dpc-221	30	20	range	range	NOUN
dpc-221	30	21	from	from	ADP
dpc-221	30	22	17	17	NUM
dpc-221	30	23	to	to	PART
dpc-221	30	24	51	51	NUM
dpc-221	30	25	years	year	NOUN
dpc-221	30	26	)	)	PUNCT
dpc-221	30	27	.	.	PUNCT
dpc-221	31	1	eight	eight	NUM
dpc-221	31	2	of	of	ADP
dpc-221	31	3	them	they	PRON
dpc-221	31	4	were	be	AUX
dpc-221	31	5	male	male	ADJ
dpc-221	31	6	(	(	PUNCT
dpc-221	31	7	27	27	NUM
dpc-221	31	8	%	%	NOUN
dpc-221	31	9	)	)	PUNCT
dpc-221	31	10	and	and	CCONJ
dpc-221	31	11	the	the	DET
dpc-221	31	12	rest	rest	NOUN
dpc-221	31	13	were	be	AUX
dpc-221	31	14	females	female	NOUN
dpc-221	31	15	(	(	PUNCT
dpc-221	31	16	73	73	NUM
dpc-221	31	17	%	%	NOUN
dpc-221	31	18	)	)	PUNCT
dpc-221	31	19	.	.	PUNCT
dpc-221	32	1	the	the	DET
dpc-221	32	2	mean	mean	ADJ
dpc-221	32	3	duration	duration	NOUN
dpc-221	32	4	of	of	ADP
dpc-221	32	5	the	the	DET
dpc-221	32	6	disease	disease	NOUN
dpc-221	32	7	was	be	AUX
dpc-221	32	8	9.4	9.4	NUM
dpc-221	32	9	months	month	NOUN
dpc-221	32	10	(	(	PUNCT
dpc-221	32	11	ranging	range	VERB
dpc-221	32	12	from	from	ADP
dpc-221	32	13	1	1	NUM
dpc-221	32	14	to	to	ADP
dpc-221	32	15	48	48	NUM
dpc-221	32	16	months	month	NOUN
dpc-221	32	17	)	)	PUNCT
dpc-221	32	18	.	.	PUNCT
dpc-221	33	1	nine	nine	NUM
dpc-221	33	2	patients	patient	NOUN
dpc-221	33	3	had	have	VERB
dpc-221	33	4	acrofacial	acrofacial	ADJ
dpc-221	33	5	vitiligo	vitiligo	NOUN
dpc-221	33	6	and	and	CCONJ
dpc-221	33	7	the	the	DET
dpc-221	33	8	rest	rest	NOUN
dpc-221	33	9	had	have	VERB
dpc-221	33	10	the	the	DET
dpc-221	33	11	segmental	segmental	ADJ
dpc-221	33	12	type	type	NOUN
dpc-221	33	13	of	of	ADP
dpc-221	33	14	the	the	DET
dpc-221	33	15	disease	disease	NOUN
dpc-221	33	16	.	.	PUNCT
dpc-221	34	1	most	most	ADJ
dpc-221	34	2	of	of	ADP
dpc-221	34	3	lesions	lesion	NOUN
dpc-221	34	4	were	be	AUX
dpc-221	34	5	located	locate	VERB
dpc-221	34	6	on	on	ADP
dpc-221	34	7	the	the	DET
dpc-221	34	8	hands	hand	NOUN
dpc-221	34	9	(	(	PUNCT
dpc-221	34	10	41.2	41.2	NUM
dpc-221	34	11	%	%	NOUN
dpc-221	34	12	)	)	PUNCT
dpc-221	34	13	,	,	PUNCT
dpc-221	34	14	followed	follow	VERB
dpc-221	34	15	by	by	ADP
dpc-221	34	16	the	the	DET
dpc-221	34	17	face	face	NOUN
dpc-221	34	18	(	(	PUNCT
dpc-221	34	19	32.3	32.3	NUM
dpc-221	34	20	%	%	NOUN
dpc-221	34	21	)	)	PUNCT
dpc-221	34	22	,	,	PUNCT
dpc-221	34	23	while	while	SCONJ
dpc-221	34	24	the	the	DET
dpc-221	34	25	remaining	remain	VERB
dpc-221	34	26	lesions	lesion	NOUN
dpc-221	34	27	were	be	AUX
dpc-221	34	28	located	locate	VERB
dpc-221	34	29	in	in	ADP
dpc-221	34	30	other	other	ADJ
dpc-221	34	31	regions	region	NOUN
dpc-221	34	32	of	of	ADP
dpc-221	34	33	the	the	DET
dpc-221	34	34	body	body	NOUN
dpc-221	34	35	(	(	PUNCT
dpc-221	34	36	26.5	26.5	NUM
dpc-221	34	37	%	%	NOUN
dpc-221	34	38	)	)	PUNCT
dpc-221	34	39	.	.	PUNCT
dpc-221	35	1	at	at	ADP
dpc-221	35	2	the	the	DET
dpc-221	35	3	end	end	NOUN
dpc-221	35	4	of	of	ADP
dpc-221	35	5	third	third	ADJ
dpc-221	35	6	month	month	NOUN
dpc-221	35	7	,	,	PUNCT
dpc-221	35	8	36.6	36.6	NUM
dpc-221	35	9	%	%	NOUN
dpc-221	35	10	(	(	PUNCT
dpc-221	35	11	n=11	n=11	NOUN
dpc-221	35	12	)	)	PUNCT
dpc-221	35	13	of	of	ADP
dpc-221	35	14	patients	patient	NOUN
dpc-221	35	15	achieved	achieve	VERB
dpc-221	35	16	approximately	approximately	ADV
dpc-221	35	17	25	25	NUM
dpc-221	35	18	%	%	NOUN
dpc-221	35	19	repigmentation	repigmentation	NOUN
dpc-221	35	20	.	.	PUNCT
dpc-221	36	1	at	at	ADP
dpc-221	36	2	the	the	DET
dpc-221	36	3	end	end	NOUN
dpc-221	36	4	of	of	ADP
dpc-221	36	5	first	first	ADJ
dpc-221	36	6	month	month	NOUN
dpc-221	36	7	,	,	PUNCT
dpc-221	36	8	only	only	ADV
dpc-221	36	9	one	one	NUM
dpc-221	36	10	patient	patient	NOUN
dpc-221	36	11	had	have	VERB
dpc-221	36	12	dramatic	dramatic	ADJ
dpc-221	36	13	response	response	NOUN
dpc-221	36	14	with	with	ADP
dpc-221	36	15	40	40	NUM
dpc-221	36	16	%	%	NOUN
dpc-221	36	17	repigmentation	repigmentation	NOUN
dpc-221	36	18	,	,	PUNCT
dpc-221	36	19	but	but	CCONJ
dpc-221	36	20	at	at	ADP
dpc-221	36	21	the	the	DET
dpc-221	36	22	end	end	NOUN
dpc-221	36	23	of	of	ADP
dpc-221	36	24	second	second	ADJ
dpc-221	36	25	month	month	NOUN
dpc-221	36	26	,	,	PUNCT
dpc-221	36	27	five	five	NUM
dpc-221	36	28	patients	patient	NOUN
dpc-221	36	29	(	(	PUNCT
dpc-221	36	30	16.6	16.6	NUM
dpc-221	36	31	%	%	NOUN
dpc-221	36	32	)	)	PUNCT
dpc-221	36	33	had	have	AUX
dpc-221	36	34	achieved	achieve	VERB
dpc-221	36	35	25	25	NUM
dpc-221	36	36	%	%	NOUN
dpc-221	36	37	repigmentation	repigmentation	NOUN
dpc-221	36	38	.	.	PUNCT
dpc-221	37	1	thirteen	thirteen	NUM
dpc-221	37	2	patients	patient	NOUN
dpc-221	37	3	had	have	VERB
dpc-221	37	4	a	a	DET
dpc-221	37	5	history	history	NOUN
dpc-221	37	6	of	of	ADP
dpc-221	37	7	previous	previous	ADJ
dpc-221	37	8	treatment	treatment	NOUN
dpc-221	37	9	with	with	ADP
dpc-221	37	10	topical	topical	ADJ
dpc-221	37	11	corticosteroids	corticosteroid	NOUN
dpc-221	37	12	and/or	and/or	CCONJ
dpc-221	37	13	topical	topical	ADJ
dpc-221	37	14	calcineurin	calcineurin	NOUN
dpc-221	37	15	inhibitors	inhibitor	NOUN
dpc-221	37	16	.	.	PUNCT
dpc-221	38	1	five	five	NUM
dpc-221	38	2	of	of	ADP
dpc-221	38	3	them	they	PRON
dpc-221	38	4	had	have	AUX
dpc-221	38	5	shown	show	VERB
dpc-221	38	6	a	a	DET
dpc-221	38	7	good	good	ADJ
dpc-221	38	8	response	response	NOUN
dpc-221	38	9	to	to	ADP
dpc-221	38	10	previous	previous	ADJ
dpc-221	38	11	treatment	treatment	NOUN
dpc-221	38	12	but	but	CCONJ
dpc-221	38	13	had	have	AUX
dpc-221	38	14	presented	present	VERB
dpc-221	38	15	with	with	ADP
dpc-221	38	16	new	new	ADJ
dpc-221	38	17	lesions	lesion	NOUN
dpc-221	38	18	.	.	PUNCT
dpc-221	39	1	one	one	NUM
dpc-221	39	2	of	of	ADP
dpc-221	39	3	the	the	DET
dpc-221	39	4	patients	patient	NOUN
dpc-221	39	5	which	which	PRON
dpc-221	39	6	had	have	AUX
dpc-221	39	7	shown	show	VERB
dpc-221	39	8	a	a	DET
dpc-221	39	9	good	good	ADJ
dpc-221	39	10	response	response	NOUN
dpc-221	39	11	to	to	ADP
dpc-221	39	12	previous	previous	ADJ
dpc-221	39	13	treatments	treatment	NOUN
dpc-221	39	14	,	,	PUNCT
dpc-221	39	15	showed	show	VERB
dpc-221	39	16	no	no	DET
dpc-221	39	17	response	response	NOUN
dpc-221	39	18	to	to	ADP
dpc-221	39	19	mmf	mmf	NOUN
dpc-221	39	20	therapy	therapy	NOUN
dpc-221	39	21	,	,	PUNCT
dpc-221	39	22	whereas	whereas	SCONJ
dpc-221	39	23	the	the	DET
dpc-221	39	24	other	other	ADJ
dpc-221	39	25	four	four	NUM
dpc-221	39	26	showed	show	VERB
dpc-221	39	27	some	some	DET
dpc-221	39	28	repigmentation	repigmentation	NOUN
dpc-221	39	29	(	(	PUNCT
dpc-221	39	30	28.8	28.8	NUM
dpc-221	39	31	%	%	NOUN
dpc-221	39	32	)	)	PUNCT
dpc-221	39	33	.	.	PUNCT
dpc-221	40	1	there	there	PRON
dpc-221	40	2	were	be	VERB
dpc-221	40	3	eight	eight	NUM
dpc-221	40	4	patients	patient	NOUN
dpc-221	40	5	who	who	PRON
dpc-221	40	6	were	be	AUX
dpc-221	40	7	resistant	resistant	ADJ
dpc-221	40	8	to	to	ADP
dpc-221	40	9	previous	previous	ADJ
dpc-221	40	10	topical	topical	ADJ
dpc-221	40	11	therapy	therapy	NOUN
dpc-221	40	12	,	,	PUNCT
dpc-221	40	13	who	who	PRON
dpc-221	40	14	also	also	ADV
dpc-221	40	15	showed	show	VERB
dpc-221	40	16	no	no	DET
dpc-221	40	17	response	response	NOUN
dpc-221	40	18	to	to	ADP
dpc-221	40	19	mmf	mmf	NOUN
dpc-221	40	20	therapy	therapy	NOUN
dpc-221	40	21	.	.	PUNCT
dpc-221	41	1	two	two	NUM
dpc-221	41	2	of	of	ADP
dpc-221	41	3	them	they	PRON
dpc-221	41	4	had	have	VERB
dpc-221	41	5	a	a	DET
dpc-221	41	6	positive	positive	ADJ
dpc-221	41	7	family	family	NOUN
dpc-221	41	8	history	history	NOUN
dpc-221	41	9	of	of	ADP
dpc-221	41	10	vitiligo	vitiligo	NOUN
dpc-221	41	11	in	in	ADP
dpc-221	41	12	their	their	PRON
dpc-221	41	13	firstor	firstor	NOUN
dpc-221	41	14	second	second	ADJ
dpc-221	41	15	-	-	PUNCT
dpc-221	41	16	degree	degree	NOUN
dpc-221	41	17	relatives	relative	NOUN
dpc-221	41	18	.	.	PUNCT
dpc-221	42	1	one	one	NUM
dpc-221	42	2	patient	patient	NOUN
dpc-221	42	3	with	with	ADP
dpc-221	42	4	a	a	DET
dpc-221	42	5	positive	positive	ADJ
dpc-221	42	6	family	family	NOUN
dpc-221	42	7	history	history	NOUN
dpc-221	42	8	of	of	ADP
dpc-221	42	9	vitiligo	vitiligo	NOUN
dpc-221	42	10	in	in	ADP
dpc-221	42	11	her	her	PRON
dpc-221	42	12	mother	mother	NOUN
dpc-221	42	13	had	have	VERB
dpc-221	42	14	a	a	DET
dpc-221	42	15	good	good	ADJ
dpc-221	42	16	response	response	NOUN
dpc-221	42	17	to	to	ADP
dpc-221	42	18	mmf	mmf	NOUN
dpc-221	42	19	therapy	therapy	NOUN
dpc-221	42	20	,	,	PUNCT
dpc-221	42	21	while	while	SCONJ
dpc-221	42	22	the	the	DET
dpc-221	42	23	other	other	ADJ
dpc-221	42	24	patient	patient	NOUN
dpc-221	42	25	with	with	ADP
dpc-221	42	26	history	history	NOUN
dpc-221	42	27	of	of	ADP
dpc-221	42	28	vitiligo	vitiligo	NOUN
dpc-221	42	29	in	in	ADP
dpc-221	42	30	his	his	PRON
dpc-221	42	31	aunt	aunt	NOUN
dpc-221	42	32	did	do	AUX
dpc-221	42	33	not	not	PART
dpc-221	42	34	respond	respond	VERB
dpc-221	42	35	to	to	ADP
dpc-221	42	36	therapy	therapy	NOUN
dpc-221	42	37	.	.	PUNCT
dpc-221	43	1	this	this	DET
dpc-221	43	2	patient	patient	NOUN
dpc-221	43	3	was	be	AUX
dpc-221	43	4	also	also	ADV
dpc-221	43	5	resistant	resistant	ADJ
dpc-221	43	6	to	to	ADP
dpc-221	43	7	previous	previous	ADJ
dpc-221	43	8	topical	topical	ADJ
dpc-221	43	9	steroid	steroid	NOUN
dpc-221	43	10	therapy	therapy	NOUN
dpc-221	43	11	.	.	PUNCT
dpc-221	44	1	all	all	DET
dpc-221	44	2	lesions	lesion	NOUN
dpc-221	44	3	that	that	PRON
dpc-221	44	4	responded	respond	VERB
dpc-221	44	5	to	to	ADP
dpc-221	44	6	mmf	mmf	NOUN
dpc-221	44	7	therapy	therapy	NOUN
dpc-221	44	8	were	be	AUX
dpc-221	44	9	in	in	ADP
dpc-221	44	10	sunexposed	sunexposed	ADJ
dpc-221	44	11	areas	area	NOUN
dpc-221	44	12	,	,	PUNCT
dpc-221	44	13	except	except	SCONJ
dpc-221	44	14	for	for	ADP
dpc-221	44	15	one	one	NUM
dpc-221	44	16	lesion	lesion	NOUN
dpc-221	44	17	,	,	PUNCT
dpc-221	44	18	which	which	PRON
dpc-221	44	19	was	be	AUX
dpc-221	44	20	on	on	ADP
dpc-221	44	21	the	the	DET
dpc-221	44	22	thigh	thigh	NOUN
dpc-221	44	23	area	area	NOUN
dpc-221	44	24	.	.	PUNCT
dpc-221	45	1	comparing	compare	VERB
dpc-221	45	2	the	the	DET
dpc-221	45	3	overall	overall	ADJ
dpc-221	45	4	pigmentation	pigmentation	NOUN
dpc-221	45	5	at	at	ADP
dpc-221	45	6	the	the	DET
dpc-221	45	7	end	end	NOUN
dpc-221	45	8	of	of	ADP
dpc-221	45	9	the	the	DET
dpc-221	45	10	second	second	ADJ
dpc-221	45	11	month	month	NOUN
dpc-221	45	12	with	with	ADP
dpc-221	45	13	the	the	DET
dpc-221	45	14	first	first	ADJ
dpc-221	45	15	month	month	NOUN
dpc-221	45	16	showed	show	VERB
dpc-221	45	17	a	a	DET
dpc-221	45	18	statistically	statistically	ADV
dpc-221	45	19	significant	significant	ADJ
dpc-221	45	20	difference	difference	NOUN
dpc-221	45	21	(	(	PUNCT
dpc-221	45	22	p.value=	p.value=	NOUN
dpc-221	45	23	0.027	0.027	NUM
dpc-221	45	24	)	)	PUNCT
dpc-221	45	25	.	.	PUNCT
dpc-221	46	1	comparing	compare	VERB
dpc-221	46	2	the	the	DET
dpc-221	46	3	overall	overall	ADJ
dpc-221	46	4	pigmentation	pigmentation	NOUN
dpc-221	46	5	at	at	ADP
dpc-221	46	6	the	the	DET
dpc-221	46	7	end	end	NOUN
dpc-221	46	8	of	of	ADP
dpc-221	46	9	the	the	DET
dpc-221	46	10	third	third	ADJ
dpc-221	46	11	month	month	NOUN
dpc-221	46	12	with	with	ADP
dpc-221	46	13	the	the	DET
dpc-221	46	14	first	first	ADJ
dpc-221	46	15	month	month	NOUN
dpc-221	46	16	showed	show	VERB
dpc-221	46	17	a	a	DET
dpc-221	46	18	statistically	statistically	ADV
dpc-221	46	19	significant	significant	ADJ
dpc-221	46	20	difference	difference	NOUN
dpc-221	46	21	(	(	PUNCT
dpc-221	46	22	p.value=	p.value=	NOUN
dpc-221	46	23	0.0.005	0.0.005	PROPN
dpc-221	46	24	)	)	PUNCT
dpc-221	46	25	(	(	PUNCT
dpc-221	46	26	table	table	NOUN
dpc-221	46	27	1	1	NUM
dpc-221	46	28	)	)	PUNCT
dpc-221	46	29	.	.	PUNCT
dpc-221	47	1	none	none	NOUN
dpc-221	47	2	of	of	ADP
dpc-221	47	3	the	the	DET
dpc-221	47	4	patients	patient	NOUN
dpc-221	47	5	presented	present	VERB
dpc-221	47	6	with	with	ADP
dpc-221	47	7	any	any	DET
dpc-221	47	8	adverse	adverse	ADJ
dpc-221	47	9	side	side	NOUN
dpc-221	47	10	effects	effect	NOUN
dpc-221	47	11	while	while	SCONJ
dpc-221	47	12	using	use	VERB
dpc-221	47	13	the	the	DET
dpc-221	47	14	topical	topical	ADJ
dpc-221	47	15	medication	medication	NOUN
dpc-221	47	16	.	.	PUNCT
dpc-221	48	1	discussion	discussion	NOUN
dpc-221	48	2	this	this	DET
dpc-221	48	3	study	study	NOUN
dpc-221	48	4	was	be	AUX
dpc-221	48	5	a	a	DET
dpc-221	48	6	pilot	pilot	NOUN
dpc-221	48	7	study	study	NOUN
dpc-221	48	8	investigating	investigate	VERB
dpc-221	48	9	the	the	DET
dpc-221	48	10	therapeutic	therapeutic	ADJ
dpc-221	48	11	effects	effect	NOUN
dpc-221	48	12	of	of	ADP
dpc-221	48	13	topical	topical	ADJ
dpc-221	48	14	mmf	mmf	NOUN
dpc-221	48	15	on	on	ADP
dpc-221	48	16	vitiligo	vitiligo	NOUN
dpc-221	48	17	patients	patient	NOUN
dpc-221	48	18	.	.	PUNCT
dpc-221	49	1	tible	tible	ADJ
dpc-221	49	2	individuals	individual	NOUN
dpc-221	49	3	is	be	AUX
dpc-221	49	4	considered	consider	VERB
dpc-221	49	5	to	to	PART
dpc-221	49	6	play	play	VERB
dpc-221	49	7	an	an	DET
dpc-221	49	8	important	important	ADJ
dpc-221	49	9	role	role	NOUN
dpc-221	49	10	[	[	X
dpc-221	49	11	3,4	3,4	NUM
dpc-221	49	12	]	]	PUNCT
dpc-221	49	13	.	.	PUNCT
dpc-221	50	1	the	the	DET
dpc-221	50	2	autoimmune	autoimmune	ADJ
dpc-221	50	3	mediated	mediate	VERB
dpc-221	50	4	destruction	destruction	NOUN
dpc-221	50	5	of	of	ADP
dpc-221	50	6	melanocytes	melanocyte	NOUN
dpc-221	50	7	is	be	AUX
dpc-221	50	8	a	a	DET
dpc-221	50	9	well	well	ADV
dpc-221	50	10	accepted	accept	VERB
dpc-221	50	11	theory	theory	NOUN
dpc-221	50	12	and	and	CCONJ
dpc-221	50	13	currently	currently	ADV
dpc-221	50	14	is	be	AUX
dpc-221	50	15	the	the	DET
dpc-221	50	16	leading	lead	VERB
dpc-221	50	17	hypothesis	hypothesis	NOUN
dpc-221	50	18	in	in	ADP
dpc-221	50	19	vitiligo	vitiligo	NOUN
dpc-221	50	20	pathogenesis	pathogenesis	NOUN
dpc-221	50	21	.	.	PUNCT
dpc-221	51	1	this	this	DET
dpc-221	51	2	immune	immune	ADJ
dpc-221	51	3	reaction	reaction	NOUN
dpc-221	51	4	is	be	AUX
dpc-221	51	5	mediated	mediate	VERB
dpc-221	51	6	by	by	ADP
dpc-221	51	7	cellular	cellular	ADJ
dpc-221	51	8	and	and	CCONJ
dpc-221	51	9	humoral	humoral	ADJ
dpc-221	51	10	immunity	immunity	NOUN
dpc-221	51	11	and	and	CCONJ
dpc-221	51	12	cytokines	cytokine	VERB
dpc-221	51	13	[	[	X
dpc-221	51	14	5	5	NUM
dpc-221	51	15	]	]	PUNCT
dpc-221	51	16	.	.	PUNCT
dpc-221	52	1	various	various	ADJ
dpc-221	52	2	treatment	treatment	NOUN
dpc-221	52	3	modalities	modality	NOUN
dpc-221	52	4	,	,	PUNCT
dpc-221	52	5	including	include	VERB
dpc-221	52	6	topical	topical	ADJ
dpc-221	52	7	therapy	therapy	NOUN
dpc-221	52	8	,	,	PUNCT
dpc-221	52	9	phototherapy	phototherapy	NOUN
dpc-221	52	10	and	and	CCONJ
dpc-221	52	11	systemic	systemic	ADJ
dpc-221	52	12	therapy	therapy	NOUN
dpc-221	52	13	have	have	AUX
dpc-221	52	14	been	be	AUX
dpc-221	52	15	used	use	VERB
dpc-221	52	16	[	[	PUNCT
dpc-221	52	17	6	6	NUM
dpc-221	52	18	-	-	SYM
dpc-221	52	19	10	10	NUM
dpc-221	52	20	]	]	PUNCT
dpc-221	52	21	,	,	PUNCT
dpc-221	52	22	but	but	CCONJ
dpc-221	52	23	no	no	DET
dpc-221	52	24	single	single	ADJ
dpc-221	52	25	treatment	treatment	NOUN
dpc-221	52	26	has	have	AUX
dpc-221	52	27	been	be	AUX
dpc-221	52	28	shown	show	VERB
dpc-221	52	29	to	to	PART
dpc-221	52	30	be	be	AUX
dpc-221	52	31	successful	successful	ADJ
dpc-221	52	32	in	in	ADP
dpc-221	52	33	all	all	DET
dpc-221	52	34	cases	case	NOUN
dpc-221	52	35	,	,	PUNCT
dpc-221	52	36	hence	hence	ADV
dpc-221	52	37	a	a	DET
dpc-221	52	38	search	search	NOUN
dpc-221	52	39	for	for	SCONJ
dpc-221	52	40	a	a	DET
dpc-221	52	41	new	new	ADJ
dpc-221	52	42	drug	drug	NOUN
dpc-221	52	43	continues	continue	VERB
dpc-221	52	44	.	.	PUNCT
dpc-221	53	1	mycophenolate	mycophenolate	PROPN
dpc-221	53	2	mofetil	mofetil	PROPN
dpc-221	53	3	(	(	PUNCT
dpc-221	53	4	mmf	mmf	NOUN
dpc-221	53	5	)	)	PUNCT
dpc-221	53	6	is	be	AUX
dpc-221	53	7	a	a	DET
dpc-221	53	8	purine	purine	NOUN
dpc-221	53	9	antagonist	antagonist	NOUN
dpc-221	53	10	that	that	PRON
dpc-221	53	11	selectively	selectively	ADV
dpc-221	53	12	inhibits	inhibit	VERB
dpc-221	53	13	proliferation	proliferation	NOUN
dpc-221	53	14	of	of	ADP
dpc-221	53	15	activated	activate	VERB
dpc-221	53	16	lymphocytes	lymphocyte	NOUN
dpc-221	53	17	.	.	PUNCT
dpc-221	54	1	mmf	mmf	NOUN
dpc-221	54	2	is	be	AUX
dpc-221	54	3	converted	convert	VERB
dpc-221	54	4	to	to	ADP
dpc-221	54	5	mycophenolic	mycophenolic	ADJ
dpc-221	54	6	acid	acid	NOUN
dpc-221	54	7	in	in	ADP
dpc-221	54	8	the	the	DET
dpc-221	54	9	human	human	ADJ
dpc-221	54	10	body	body	NOUN
dpc-221	54	11	which	which	PRON
dpc-221	54	12	then	then	ADV
dpc-221	54	13	inhibits	inhibit	VERB
dpc-221	54	14	inosine	inosine	NOUN
dpc-221	54	15	monophosphate	monophosphate	NOUN
dpc-221	54	16	dehydrogenase	dehydrogenase	NOUN
dpc-221	54	17	.	.	PUNCT
dpc-221	55	1	this	this	DET
dpc-221	55	2	enzyme	enzyme	NOUN
dpc-221	55	3	converts	convert	VERB
dpc-221	55	4	inosine	inosine	NOUN
dpc-221	55	5	monophosphate	monophosphate	NOUN
dpc-221	55	6	to	to	AUX
dpc-221	55	7	guanosine	guanosine	VERB
dpc-221	55	8	monophosphate	monophosphate	NOUN
dpc-221	55	9	.	.	PUNCT
dpc-221	56	1	in	in	ADP
dpc-221	56	2	fact	fact	NOUN
dpc-221	56	3	,	,	PUNCT
dpc-221	56	4	mmf	mmf	NOUN
dpc-221	56	5	inhibits	inhibit	VERB
dpc-221	56	6	dna	dna	PROPN
dpc-221	56	7	synthesis	synthesis	NOUN
dpc-221	56	8	in	in	ADP
dpc-221	56	9	lymphocytes	lymphocyte	NOUN
dpc-221	56	10	,	,	PUNCT
dpc-221	56	11	and	and	CCONJ
dpc-221	56	12	inhibits	inhibit	VERB
dpc-221	56	13	the	the	DET
dpc-221	56	14	production	production	NOUN
dpc-221	56	15	of	of	ADP
dpc-221	56	16	antibody	antibody	NOUN
dpc-221	56	17	by	by	ADP
dpc-221	56	18	b	b	NOUN
dpc-221	56	19	-	-	PUNCT
dpc-221	56	20	cells	cell	NOUN
dpc-221	56	21	.	.	PUNCT
dpc-221	57	1	the	the	DET
dpc-221	57	2	drug	drug	NOUN
dpc-221	57	3	prevents	prevent	VERB
dpc-221	57	4	glycosylation	glycosylation	NOUN
dpc-221	57	5	and	and	CCONJ
dpc-221	57	6	expression	expression	NOUN
dpc-221	57	7	of	of	ADP
dpc-221	57	8	binding	bind	VERB
dpc-221	57	9	molecules	molecule	NOUN
dpc-221	57	10	and	and	CCONJ
dpc-221	57	11	the	the	DET
dpc-221	57	12	summoning	summoning	NOUN
dpc-221	57	13	of	of	ADP
dpc-221	57	14	lymphocytes	lymphocyte	NOUN
dpc-221	57	15	and	and	CCONJ
dpc-221	57	16	monocytes	monocyte	VERB
dpc-221	57	17	into	into	ADP
dpc-221	57	18	sites	site	NOUN
dpc-221	57	19	of	of	ADP
dpc-221	57	20	inflammation	inflammation	NOUN
dpc-221	57	21	[	[	X
dpc-221	57	22	11	11	NUM
dpc-221	57	23	]	]	PUNCT
dpc-221	57	24	.	.	PUNCT
dpc-221	58	1	mmf	mmf	NOUN
dpc-221	58	2	can	can	AUX
dpc-221	58	3	induce	induce	VERB
dpc-221	58	4	apoptosis	apoptosis	NOUN
dpc-221	58	5	of	of	ADP
dpc-221	58	6	activated	activated	ADJ
dpc-221	58	7	lymphocytes	lymphocyte	NOUN
dpc-221	58	8	and	and	CCONJ
dpc-221	58	9	decrease	decrease	VERB
dpc-221	58	10	the	the	DET
dpc-221	58	11	recruitment	recruitment	NOUN
dpc-221	58	12	of	of	ADP
dpc-221	58	13	lymphocytes	lymphocyte	NOUN
dpc-221	58	14	(	(	PUNCT
dpc-221	58	15	both	both	CCONJ
dpc-221	58	16	cd4	cd4	PROPN
dpc-221	58	17	and	and	CCONJ
dpc-221	58	18	cd8	cd8	PROPN
dpc-221	58	19	)	)	PUNCT
dpc-221	58	20	and	and	CCONJ
dpc-221	58	21	monocytes	monocyte	VERB
dpc-221	58	22	into	into	ADP
dpc-221	58	23	inflammation	inflammation	NOUN
dpc-221	58	24	sites	site	NOUN
dpc-221	58	25	[	[	X
dpc-221	58	26	12	12	NUM
dpc-221	58	27	]	]	PUNCT
dpc-221	58	28	.	.	PUNCT
dpc-221	59	1	lee	lee	PROPN
dpc-221	59	2	yf	yf	INTJ
dpc-221	59	3	et	et	PROPN
dpc-221	59	4	al	al	PROPN
dpc-221	59	5	showed	show	VERB
dpc-221	59	6	that	that	SCONJ
dpc-221	59	7	the	the	DET
dpc-221	59	8	recruitment	recruitment	NOUN
dpc-221	59	9	of	of	ADP
dpc-221	59	10	cd8	cd8	PROPN
dpc-221	59	11	lymphocytes	lymphocyte	VERB
dpc-221	59	12	to	to	ADP
dpc-221	59	13	the	the	DET
dpc-221	59	14	skin	skin	NOUN
dpc-221	59	15	was	be	AUX
dpc-221	59	16	significantly	significantly	ADV
dpc-221	59	17	decreased	decrease	VERB
dpc-221	59	18	after	after	ADP
dpc-221	59	19	mmf	mmf	NOUN
dpc-221	59	20	therapy	therapy	NOUN
dpc-221	59	21	[	[	X
dpc-221	59	22	13	13	NUM
dpc-221	59	23	]	]	PUNCT
dpc-221	59	24	.	.	PUNCT
dpc-221	60	1	therefore	therefore	ADV
dpc-221	60	2	,	,	PUNCT
dpc-221	60	3	the	the	DET
dpc-221	60	4	use	use	NOUN
dpc-221	60	5	of	of	ADP
dpc-221	60	6	it	it	PRON
dpc-221	60	7	could	could	AUX
dpc-221	60	8	theoretically	theoretically	ADV
dpc-221	60	9	help	help	VERB
dpc-221	60	10	in	in	ADP
dpc-221	60	11	the	the	DET
dpc-221	60	12	management	management	NOUN
dpc-221	60	13	of	of	ADP
dpc-221	60	14	vitiligo	vitiligo	NOUN
dpc-221	60	15	.	.	PUNCT
dpc-221	61	1	objective	objective	VERB
dpc-221	61	2	the	the	DET
dpc-221	61	3	objective	objective	NOUN
dpc-221	61	4	of	of	ADP
dpc-221	61	5	this	this	DET
dpc-221	61	6	study	study	NOUN
dpc-221	61	7	was	be	AUX
dpc-221	61	8	to	to	PART
dpc-221	61	9	assess	assess	VERB
dpc-221	61	10	the	the	DET
dpc-221	61	11	efficacy	efficacy	NOUN
dpc-221	61	12	of	of	ADP
dpc-221	61	13	topical	topical	ADJ
dpc-221	61	14	mmf	mmf	NOUN
dpc-221	61	15	in	in	ADP
dpc-221	61	16	the	the	DET
dpc-221	61	17	treatment	treatment	NOUN
dpc-221	61	18	of	of	ADP
dpc-221	61	19	vitiligo	vitiligo	NOUN
dpc-221	61	20	.	.	PUNCT
dpc-221	62	1	to	to	ADP
dpc-221	62	2	our	our	PRON
dpc-221	62	3	knowledge	knowledge	NOUN
dpc-221	62	4	,	,	PUNCT
dpc-221	62	5	there	there	PRON
dpc-221	62	6	is	be	VERB
dpc-221	62	7	no	no	DET
dpc-221	62	8	such	such	ADJ
dpc-221	62	9	study	study	NOUN
dpc-221	62	10	in	in	ADP
dpc-221	62	11	the	the	DET
dpc-221	62	12	literature	literature	NOUN
dpc-221	62	13	to	to	ADP
dpc-221	62	14	date	date	NOUN
dpc-221	62	15	.	.	PUNCT
dpc-221	63	1	methods	method	NOUN
dpc-221	63	2	this	this	DET
dpc-221	63	3	study	study	NOUN
dpc-221	63	4	was	be	AUX
dpc-221	63	5	conducted	conduct	VERB
dpc-221	63	6	at	at	ADP
dpc-221	63	7	the	the	DET
dpc-221	63	8	department	department	NOUN
dpc-221	63	9	of	of	ADP
dpc-221	63	10	dermatology	dermatology	NOUN
dpc-221	63	11	,	,	PUNCT
dpc-221	63	12	shahid	shahid	PROPN
dpc-221	63	13	faghihi	faghihi	PROPN
dpc-221	63	14	university	university	PROPN
dpc-221	63	15	hospital	hospital	PROPN
dpc-221	63	16	,	,	PUNCT
dpc-221	63	17	shiraz	shiraz	PROPN
dpc-221	63	18	,	,	PUNCT
dpc-221	63	19	iran	iran	PROPN
dpc-221	63	20	over	over	ADP
dpc-221	63	21	a	a	DET
dpc-221	63	22	14	14	NUM
dpc-221	63	23	-	-	PUNCT
dpc-221	63	24	month	month	NOUN
dpc-221	63	25	period	period	NOUN
dpc-221	63	26	.	.	PUNCT
dpc-221	64	1	thirty	thirty	NUM
dpc-221	64	2	patients	patient	NOUN
dpc-221	64	3	were	be	AUX
dpc-221	64	4	enrolled	enrol	VERB
dpc-221	64	5	in	in	ADP
dpc-221	64	6	this	this	DET
dpc-221	64	7	pilot	pilot	NOUN
dpc-221	64	8	study	study	NOUN
dpc-221	64	9	.	.	PUNCT
dpc-221	65	1	all	all	DET
dpc-221	65	2	patients	patient	NOUN
dpc-221	65	3	had	have	VERB
dpc-221	65	4	limited	limit	VERB
dpc-221	65	5	vitiligo	vitiligo	NOUN
dpc-221	65	6	(	(	PUNCT
dpc-221	65	7	less	less	ADJ
dpc-221	65	8	than	than	ADP
dpc-221	65	9	5	5	NUM
dpc-221	65	10	%	%	NOUN
dpc-221	65	11	of	of	ADP
dpc-221	65	12	total	total	ADJ
dpc-221	65	13	body	body	NOUN
dpc-221	65	14	surface	surface	NOUN
dpc-221	65	15	area	area	NOUN
dpc-221	65	16	)	)	PUNCT
dpc-221	65	17	and	and	CCONJ
dpc-221	65	18	had	have	AUX
dpc-221	65	19	either	either	CCONJ
dpc-221	65	20	received	receive	VERB
dpc-221	65	21	no	no	DET
dpc-221	65	22	previous	previous	ADJ
dpc-221	65	23	treatment	treatment	NOUN
dpc-221	65	24	or	or	CCONJ
dpc-221	65	25	three	three	NUM
dpc-221	65	26	months	month	NOUN
dpc-221	65	27	had	have	AUX
dpc-221	65	28	elapsed	elapse	VERB
dpc-221	65	29	since	since	SCONJ
dpc-221	65	30	their	their	PRON
dpc-221	65	31	last	last	ADJ
dpc-221	65	32	treatment	treatment	NOUN
dpc-221	65	33	plan	plan	NOUN
dpc-221	65	34	.	.	PUNCT
dpc-221	66	1	patients	patient	NOUN
dpc-221	66	2	with	with	ADP
dpc-221	66	3	mucosal	mucosal	NOUN
dpc-221	66	4	vitiligo	vitiligo	NOUN
dpc-221	66	5	,	,	PUNCT
dpc-221	66	6	pregnant	pregnant	ADJ
dpc-221	66	7	and	and	CCONJ
dpc-221	66	8	lactating	lactate	VERB
dpc-221	66	9	women	woman	NOUN
dpc-221	66	10	,	,	PUNCT
dpc-221	66	11	children	child	NOUN
dpc-221	66	12	and	and	CCONJ
dpc-221	66	13	neutropenic	neutropenic	ADJ
dpc-221	66	14	patients	patient	NOUN
dpc-221	66	15	were	be	AUX
dpc-221	66	16	excluded	exclude	VERB
dpc-221	66	17	due	due	ADJ
dpc-221	66	18	to	to	ADP
dpc-221	66	19	probable	probable	ADJ
dpc-221	66	20	side	side	NOUN
dpc-221	66	21	effects	effect	NOUN
dpc-221	66	22	of	of	ADP
dpc-221	66	23	mmf	mmf	NOUN
dpc-221	66	24	on	on	ADP
dpc-221	66	25	these	these	DET
dpc-221	66	26	patients	patient	NOUN
dpc-221	66	27	.	.	PUNCT
dpc-221	67	1	the	the	DET
dpc-221	67	2	patients	patient	NOUN
dpc-221	67	3	were	be	AUX
dpc-221	67	4	instructed	instruct	VERB
dpc-221	67	5	to	to	PART
dpc-221	67	6	apply	apply	VERB
dpc-221	67	7	topical	topical	ADJ
dpc-221	67	8	mmf	mmf	NOUN
dpc-221	67	9	15	15	NUM
dpc-221	67	10	%	%	NOUN
dpc-221	67	11	preparation	preparation	NOUN
dpc-221	67	12	twice	twice	ADV
dpc-221	67	13	daily	daily	ADV
dpc-221	67	14	for	for	ADP
dpc-221	67	15	three	three	NUM
dpc-221	67	16	months	month	NOUN
dpc-221	67	17	,	,	PUNCT
dpc-221	67	18	and	and	CCONJ
dpc-221	67	19	at	at	ADP
dpc-221	67	20	the	the	DET
dpc-221	67	21	end	end	NOUN
dpc-221	67	22	of	of	ADP
dpc-221	67	23	every	every	DET
dpc-221	67	24	month	month	NOUN
dpc-221	67	25	repigmentation	repigmentation	NOUN
dpc-221	67	26	was	be	AUX
dpc-221	67	27	assessed	assess	VERB
dpc-221	67	28	using	use	VERB
dpc-221	67	29	the	the	DET
dpc-221	67	30	vitiligo	vitiligo	NOUN
dpc-221	67	31	area	area	NOUN
dpc-221	67	32	scoring	scoring	NOUN
dpc-221	67	33	index	index	NOUN
dpc-221	67	34	(	(	PUNCT
dpc-221	67	35	vasi	vasi	PROPN
dpc-221	67	36	)	)	PUNCT
dpc-221	67	37	for	for	ADP
dpc-221	67	38	every	every	DET
dpc-221	67	39	patient	patient	NOUN
dpc-221	67	40	.	.	PUNCT
dpc-221	68	1	the	the	DET
dpc-221	68	2	reason	reason	NOUN
dpc-221	68	3	for	for	ADP
dpc-221	68	4	choosing	choose	VERB
dpc-221	68	5	a	a	DET
dpc-221	68	6	15	15	NUM
dpc-221	68	7	%	%	NOUN
dpc-221	68	8	concentration	concentration	NOUN
dpc-221	68	9	of	of	ADP
dpc-221	68	10	mmf	mmf	NOUN
dpc-221	68	11	was	be	AUX
dpc-221	68	12	that	that	SCONJ
dpc-221	68	13	this	this	PRON
dpc-221	68	14	was	be	AUX
dpc-221	68	15	the	the	DET
dpc-221	68	16	maximum	maximum	ADJ
dpc-221	68	17	concentration	concentration	NOUN
dpc-221	68	18	that	that	PRON
dpc-221	68	19	could	could	AUX
dpc-221	68	20	be	be	AUX
dpc-221	68	21	obtained	obtain	VERB
dpc-221	68	22	by	by	ADP
dpc-221	68	23	dissolving	dissolve	VERB
dpc-221	68	24	the	the	DET
dpc-221	68	25	mmf	mmf	NOUN
dpc-221	68	26	tablets	tablet	NOUN
dpc-221	68	27	(	(	PUNCT
dpc-221	68	28	500	500	NUM
dpc-221	68	29	mg	mg	PROPN
dpc-221	68	30	tablet	tablet	NOUN
dpc-221	68	31	,	,	PUNCT
dpc-221	68	32	actoverco	actoverco	NOUN
dpc-221	68	33	company	company	NOUN
dpc-221	68	34	,	,	PUNCT
dpc-221	68	35	iran	iran	PROPN
dpc-221	68	36	)	)	PUNCT
dpc-221	68	37	in	in	ADP
dpc-221	68	38	eucerin	eucerin	NOUN
dpc-221	68	39	®	®	NOUN
dpc-221	68	40	.	.	PUNCT
dpc-221	69	1	this	this	DET
dpc-221	69	2	study	study	NOUN
dpc-221	69	3	was	be	AUX
dpc-221	69	4	approved	approve	VERB
dpc-221	69	5	by	by	ADP
dpc-221	69	6	the	the	DET
dpc-221	69	7	ethical	ethical	PROPN
dpc-221	69	8	committee	committee	NOUN
dpc-221	69	9	of	of	ADP
dpc-221	69	10	shiraz	shiraz	PROPN
dpc-221	69	11	university	university	PROPN
dpc-221	69	12	of	of	ADP
dpc-221	69	13	research	research	NOUN
dpc-221	69	14	|	|	ADV
dpc-221	70	1	dermatol	dermatol	ADJ
dpc-221	70	2	pract	pract	NOUN
dpc-221	70	3	concept	concept	NOUN
dpc-221	70	4	2017;7(2):6	2017;7(2):6	PROPN
dpc-221	70	5	33	33	NUM
dpc-221	70	6	it	it	PRON
dpc-221	70	7	seems	seem	VERB
dpc-221	70	8	that	that	SCONJ
dpc-221	70	9	although	although	SCONJ
dpc-221	70	10	the	the	DET
dpc-221	70	11	use	use	NOUN
dpc-221	70	12	of	of	ADP
dpc-221	70	13	topical	topical	ADJ
dpc-221	70	14	mmf	mmf	NOUN
dpc-221	70	15	in	in	ADP
dpc-221	70	16	the	the	DET
dpc-221	70	17	treatment	treatment	NOUN
dpc-221	70	18	of	of	ADP
dpc-221	70	19	vitiligo	vitiligo	NOUN
dpc-221	70	20	can	can	AUX
dpc-221	70	21	be	be	AUX
dpc-221	70	22	effective	effective	ADJ
dpc-221	70	23	,	,	PUNCT
dpc-221	70	24	its	its	PRON
dpc-221	70	25	use	use	NOUN
dpc-221	70	26	may	may	AUX
dpc-221	70	27	not	not	PART
dpc-221	70	28	be	be	AUX
dpc-221	70	29	warranted	warrant	VERB
dpc-221	70	30	in	in	ADP
dpc-221	70	31	cases	case	NOUN
dpc-221	70	32	resistant	resistant	ADJ
dpc-221	70	33	to	to	ADP
dpc-221	70	34	topical	topical	ADJ
dpc-221	70	35	steroids	steroid	NOUN
dpc-221	70	36	.	.	PUNCT
dpc-221	71	1	however	however	ADV
dpc-221	71	2	,	,	PUNCT
dpc-221	71	3	due	due	ADP
dpc-221	71	4	to	to	ADP
dpc-221	71	5	its	its	PRON
dpc-221	71	6	safety	safety	NOUN
dpc-221	71	7	,	,	PUNCT
dpc-221	71	8	it	it	PRON
dpc-221	71	9	can	can	AUX
dpc-221	71	10	be	be	AUX
dpc-221	71	11	considered	consider	VERB
dpc-221	71	12	in	in	ADP
dpc-221	71	13	cases	case	NOUN
dpc-221	71	14	where	where	SCONJ
dpc-221	71	15	the	the	DET
dpc-221	71	16	use	use	NOUN
dpc-221	71	17	of	of	ADP
dpc-221	71	18	topical	topical	ADJ
dpc-221	71	19	steroids	steroid	NOUN
dpc-221	71	20	is	be	AUX
dpc-221	71	21	contraindicated	contraindicate	VERB
dpc-221	71	22	or	or	CCONJ
dpc-221	71	23	can	can	AUX
dpc-221	71	24	cause	cause	VERB
dpc-221	71	25	significant	significant	ADJ
dpc-221	71	26	atrophy	atrophy	NOUN
dpc-221	71	27	.	.	PUNCT
dpc-221	72	1	acknowledgements	acknowledgement	VERB
dpc-221	72	2	the	the	DET
dpc-221	72	3	present	present	ADJ
dpc-221	72	4	article	article	NOUN
dpc-221	72	5	was	be	AUX
dpc-221	72	6	extracted	extract	VERB
dpc-221	72	7	from	from	ADP
dpc-221	72	8	the	the	DET
dpc-221	72	9	thesis	thesis	NOUN
dpc-221	72	10	written	write	VERB
dpc-221	72	11	by	by	ADP
dpc-221	72	12	dr	dr	PROPN
dpc-221	72	13	.	.	PROPN
dpc-221	72	14	iman	iman	PROPN
dpc-221	72	15	moezzin	moezzin	PROPN
dpc-221	72	16	and	and	CCONJ
dpc-221	72	17	was	be	AUX
dpc-221	72	18	financially	financially	ADV
dpc-221	72	19	supported	support	VERB
dpc-221	72	20	by	by	ADP
dpc-221	72	21	shiraz	shiraz	PROPN
dpc-221	72	22	university	university	PROPN
dpc-221	72	23	of	of	ADP
dpc-221	72	24	medical	medical	ADJ
dpc-221	72	25	sciences	science	NOUN
dpc-221	72	26	grant	grant	VERB
dpc-221	72	27	no.92	no.92	NOUN
dpc-221	72	28	-	-	PUNCT
dpc-221	72	29	01	01	NUM
dpc-221	72	30	-	-	PUNCT
dpc-221	72	31	01	01	NUM
dpc-221	72	32	-	-	PUNCT
dpc-221	72	33	6771	6771	NUM
dpc-221	72	34	.	.	PUNCT
dpc-221	73	1	references	reference	NOUN
dpc-221	73	2	1	1	NUM
dpc-221	73	3	.	.	PUNCT
dpc-221	74	1	alikhan	alikhan	PROPN
dpc-221	74	2	a	a	DET
dpc-221	74	3	,	,	PUNCT
dpc-221	74	4	felsten	felsten	ADJ
dpc-221	74	5	lm	lm	PROPN
dpc-221	74	6	,	,	PUNCT
dpc-221	74	7	daly	daly	PROPN
dpc-221	74	8	m	m	PROPN
dpc-221	74	9	,	,	PUNCT
dpc-221	74	10	petronic	petronic	ADJ
dpc-221	74	11	-	-	PUNCT
dpc-221	74	12	rosic	rosic	NOUN
dpc-221	74	13	v.	v.	ADP
dpc-221	74	14	vitiligo	vitiligo	NOUN
dpc-221	74	15	:	:	PUNCT
dpc-221	74	16	a	a	DET
dpc-221	74	17	comprehensive	comprehensive	ADJ
dpc-221	74	18	overview	overview	NOUN
dpc-221	74	19	.	.	PUNCT
dpc-221	75	1	part	part	NOUN
dpc-221	75	2	1	1	NUM
dpc-221	75	3	.	.	PUNCT
dpc-221	75	4	introduction	introduction	NOUN
dpc-221	75	5	,	,	PUNCT
dpc-221	75	6	epidemiology	epidemiology	NOUN
dpc-221	75	7	,	,	PUNCT
dpc-221	75	8	quality	quality	NOUN
dpc-221	75	9	of	of	ADP
dpc-221	75	10	life	life	NOUN
dpc-221	75	11	,	,	PUNCT
dpc-221	75	12	diagnosis	diagnosis	NOUN
dpc-221	75	13	,	,	PUNCT
dpc-221	75	14	differential	differential	ADJ
dpc-221	75	15	diagnosis	diagnosis	NOUN
dpc-221	75	16	,	,	PUNCT
dpc-221	75	17	associations	association	NOUN
dpc-221	75	18	,	,	PUNCT
dpc-221	75	19	histopathology	histopathology	NOUN
dpc-221	75	20	,	,	PUNCT
dpc-221	75	21	etiology	etiology	NOUN
dpc-221	75	22	,	,	PUNCT
dpc-221	75	23	and	and	CCONJ
dpc-221	75	24	work	work	NOUN
dpc-221	75	25	-	-	PUNCT
dpc-221	75	26	up	up	NOUN
dpc-221	75	27	.	.	PUNCT
dpc-221	76	1	j	j	PROPN
dpc-221	76	2	am	be	AUX
dpc-221	76	3	acad	acad	ADJ
dpc-221	76	4	dermatol	dermatol	NOUN
dpc-221	76	5	.	.	PUNCT
dpc-221	77	1	2011;65(3):473	2011;65(3):473	NUM
dpc-221	77	2	-	-	SYM
dpc-221	77	3	491	491	NUM
dpc-221	77	4	.	.	PUNCT
dpc-221	78	1	2	2	X
dpc-221	78	2	.	.	X
dpc-221	78	3	hamzavi	hamzavi	PROPN
dpc-221	78	4	ih	ih	PROPN
dpc-221	78	5	,	,	PUNCT
dpc-221	78	6	mahmoud	mahmoud	PROPN
dpc-221	78	7	bh	bh	PROPN
dpc-221	78	8	,	,	PUNCT
dpc-221	78	9	isedeh	isedeh	PROPN
dpc-221	78	10	pn	pn	PROPN
dpc-221	78	11	.	.	PROPN
dpc-221	78	12	handbook	handbook	PROPN
dpc-221	78	13	of	of	ADP
dpc-221	78	14	vitiligo	vitiligo	NOUN
dpc-221	78	15	:	:	PUNCT
dpc-221	78	16	basic	basic	ADJ
dpc-221	78	17	science	science	NOUN
dpc-221	78	18	and	and	CCONJ
dpc-221	78	19	clinical	clinical	ADJ
dpc-221	78	20	management	management	NOUN
dpc-221	78	21	.	.	PUNCT
dpc-221	79	1	jp	jp	PROPN
dpc-221	79	2	medical	medical	PROPN
dpc-221	79	3	ltd	ltd	PROPN
dpc-221	79	4	:	:	PUNCT
dpc-221	79	5	london	london	PROPN
dpc-221	79	6	2015:1	2015:1	NUM
dpc-221	79	7	-	-	SYM
dpc-221	79	8	21	21	NUM
dpc-221	79	9	.	.	PUNCT
dpc-221	80	1	3	3	NUM
dpc-221	80	2	.	.	NOUN
dpc-221	80	3	westerhof	westerhof	PROPN
dpc-221	80	4	w	w	PROPN
dpc-221	80	5	,	,	PUNCT
dpc-221	80	6	d’ischia	d’ischia	PROPN
dpc-221	80	7	m.	m.	NOUN
dpc-221	80	8	vitiligo	vitiligo	NOUN
dpc-221	80	9	puzzle	puzzle	NOUN
dpc-221	80	10	the	the	DET
dpc-221	80	11	pieces	piece	NOUN
dpc-221	80	12	fall	fall	VERB
dpc-221	80	13	in	in	ADP
dpc-221	80	14	place	place	NOUN
dpc-221	80	15	.	.	PUNCT
dpc-221	81	1	pigment	pigment	NOUN
dpc-221	81	2	cell	cell	NOUN
dpc-221	81	3	res	re	NOUN
dpc-221	81	4	.	.	PUNCT
dpc-221	82	1	2007;20(5):345	2007;20(5):345	NUM
dpc-221	82	2	-	-	SYM
dpc-221	82	3	359	359	NUM
dpc-221	82	4	.	.	PUNCT
dpc-221	83	1	4	4	X
dpc-221	83	2	.	.	X
dpc-221	83	3	passeron	passeron	PROPN
dpc-221	83	4	t	t	PROPN
dpc-221	83	5	,	,	PUNCT
dpc-221	83	6	ortonne	ortonne	NOUN
dpc-221	83	7	jp	jp	NOUN
dpc-221	83	8	.	.	PUNCT
dpc-221	84	1	physiopathology	physiopathology	NOUN
dpc-221	84	2	and	and	CCONJ
dpc-221	84	3	genetics	genetic	NOUN
dpc-221	84	4	of	of	ADP
dpc-221	84	5	vitiligo	vitiligo	NOUN
dpc-221	84	6	.	.	PUNCT
dpc-221	85	1	j	j	PROPN
dpc-221	85	2	autoimmun	autoimmun	PROPN
dpc-221	85	3	.	.	PUNCT
dpc-221	86	1	2005;25	2005;25	NOUN
dpc-221	86	2	suppl:63	suppl:63	PROPN
dpc-221	86	3	-	-	PUNCT
dpc-221	86	4	68	68	NUM
dpc-221	86	5	.	.	PUNCT
dpc-221	87	1	5	5	NUM
dpc-221	87	2	.	.	X
dpc-221	87	3	abreu	abreu	PROPN
dpc-221	87	4	ac	ac	PROPN
dpc-221	87	5	,	,	PUNCT
dpc-221	87	6	duarte	duarte	PROPN
dpc-221	87	7	gg	gg	PROPN
dpc-221	87	8	,	,	PUNCT
dpc-221	87	9	miranda	miranda	PROPN
dpc-221	87	10	jy	jy	PROPN
dpc-221	87	11	,	,	PUNCT
dpc-221	87	12	ramos	ramos	PROPN
dpc-221	87	13	dg	dg	PROPN
dpc-221	87	14	,	,	PUNCT
dpc-221	87	15	ramos	ramos	PROPN
dpc-221	87	16	cg	cg	PROPN
dpc-221	87	17	,	,	PUNCT
dpc-221	87	18	ramos	ramos	PROPN
dpc-221	87	19	mg	mg	PROPN
dpc-221	87	20	.	.	PUNCT
dpc-221	88	1	immunological	immunological	ADJ
dpc-221	88	2	parameters	parameter	NOUN
dpc-221	88	3	associated	associate	VERB
dpc-221	88	4	with	with	ADP
dpc-221	88	5	vitiligo	vitiligo	ADJ
dpc-221	88	6	treatments	treatment	NOUN
dpc-221	88	7	.	.	PUNCT
dpc-221	89	1	a	a	DET
dpc-221	89	2	literature	literature	NOUN
dpc-221	89	3	review	review	NOUN
dpc-221	89	4	based	base	VERB
dpc-221	89	5	on	on	ADP
dpc-221	89	6	clinical	clinical	ADJ
dpc-221	89	7	studies	study	NOUN
dpc-221	89	8	.	.	PUNCT
dpc-221	90	1	autoimmune	autoimmune	PROPN
dpc-221	90	2	dis	dis	PROPN
dpc-221	90	3	.	.	PUNCT
dpc-221	91	1	2015;2015:196537	2015;2015:196537	NUM
dpc-221	91	2	.	.	NOUN
dpc-221	92	1	6	6	NUM
dpc-221	92	2	.	.	X
dpc-221	92	3	jalel	jalel	VERB
dpc-221	92	4	a	a	PRON
dpc-221	92	5	,	,	PUNCT
dpc-221	92	6	soumaya	soumaya	PROPN
dpc-221	92	7	gs	gs	PROPN
dpc-221	92	8	,	,	PUNCT
dpc-221	92	9	hamdaoui	hamdaoui	PROPN
dpc-221	92	10	mh	mh	PROPN
dpc-221	92	11	.	.	PUNCT
dpc-221	93	1	vitiligo	vitiligo	PROPN
dpc-221	93	2	treatment	treatment	NOUN
dpc-221	93	3	with	with	ADP
dpc-221	93	4	vitamins	vitamin	NOUN
dpc-221	93	5	,	,	PUNCT
dpc-221	93	6	minerals	mineral	NOUN
dpc-221	93	7	and	and	CCONJ
dpc-221	93	8	polyphenol	polyphenol	NOUN
dpc-221	93	9	supplementation	supplementation	NOUN
dpc-221	93	10	.	.	PUNCT
dpc-221	94	1	indian	indian	PROPN
dpc-221	94	2	j	j	PROPN
dpc-221	94	3	dermatol	dermatol	NOUN
dpc-221	94	4	.	.	PUNCT
dpc-221	95	1	2009;54(4):357	2009;54(4):357	NOUN
dpc-221	95	2	-	-	SYM
dpc-221	95	3	360	360	NUM
dpc-221	95	4	.	.	PUNCT
dpc-221	96	1	7	7	X
dpc-221	96	2	.	.	X
dpc-221	96	3	taieb	taieb	PROPN
dpc-221	96	4	a	a	PRON
dpc-221	96	5	,	,	PUNCT
dpc-221	96	6	alomar	alomar	PROPN
dpc-221	96	7	a	a	PROPN
dpc-221	96	8	,	,	PUNCT
dpc-221	96	9	bohm	bohm	PROPN
dpc-221	96	10	m	m	PROPN
dpc-221	96	11	,	,	PUNCT
dpc-221	96	12	et	et	PROPN
dpc-221	96	13	al	al	PROPN
dpc-221	96	14	.	.	PUNCT
dpc-221	96	15	guidelines	guideline	NOUN
dpc-221	96	16	for	for	ADP
dpc-221	96	17	the	the	DET
dpc-221	96	18	management	management	NOUN
dpc-221	96	19	of	of	ADP
dpc-221	96	20	vitiligo	vitiligo	NOUN
dpc-221	96	21	:	:	PUNCT
dpc-221	96	22	the	the	DET
dpc-221	96	23	european	european	PROPN
dpc-221	96	24	dermatology	dermatology	PROPN
dpc-221	96	25	forum	forum	PROPN
dpc-221	96	26	consensus	consensus	PROPN
dpc-221	96	27	.	.	PUNCT
dpc-221	97	1	br	br	PROPN
dpc-221	97	2	j	j	PROPN
dpc-221	97	3	dermatol	dermatol	NOUN
dpc-221	97	4	.	.	PUNCT
dpc-221	98	1	2013;168:5	2013;168:5	NUM
dpc-221	98	2	-	-	SYM
dpc-221	98	3	19	19	NUM
dpc-221	98	4	.	.	NOUN
dpc-221	98	5	8	8	NUM
dpc-221	98	6	.	.	PUNCT
dpc-221	98	7	gawkrodger	gawkrodger	PROPN
dpc-221	98	8	dj	dj	PROPN
dpc-221	98	9	,	,	PUNCT
dpc-221	98	10	ormerod	ormerod	VERB
dpc-221	98	11	ad	ad	NOUN
dpc-221	98	12	,	,	PUNCT
dpc-221	98	13	shaw	shaw	PROPN
dpc-221	98	14	l	l	PROPN
dpc-221	98	15	,	,	PUNCT
dpc-221	98	16	et	et	PROPN
dpc-221	98	17	al	al	PROPN
dpc-221	98	18	.	.	PROPN
dpc-221	98	19	guideline	guideline	NOUN
dpc-221	98	20	for	for	ADP
dpc-221	98	21	the	the	DET
dpc-221	98	22	diagnosis	diagnosis	NOUN
dpc-221	98	23	and	and	CCONJ
dpc-221	98	24	management	management	NOUN
dpc-221	98	25	of	of	ADP
dpc-221	98	26	vitiligo	vitiligo	NOUN
dpc-221	98	27	.	.	PUNCT
dpc-221	99	1	br	br	PROPN
dpc-221	99	2	j	j	PROPN
dpc-221	99	3	dermatol	dermatol	NOUN
dpc-221	99	4	.	.	PUNCT
dpc-221	99	5	2008	2008	NUM
dpc-221	99	6	;	;	PUNCT
dpc-221	99	7	159:1051	159:1051	NUM
dpc-221	99	8	-	-	SYM
dpc-221	99	9	1076	1076	NUM
dpc-221	99	10	.	.	PUNCT
dpc-221	100	1	9	9	X
dpc-221	100	2	.	.	X
dpc-221	100	3	yones	yones	PROPN
dpc-221	100	4	ss	ss	PROPN
dpc-221	100	5	,	,	PUNCT
dpc-221	100	6	palmer	palmer	PROPN
dpc-221	100	7	ra	ra	PROPN
dpc-221	100	8	,	,	PUNCT
dpc-221	100	9	garibaldinos	garibaldinos	PROPN
dpc-221	100	10	tm	tm	PROPN
dpc-221	100	11	,	,	PUNCT
dpc-221	100	12	hawk	hawk	VERB
dpc-221	100	13	jl	jl	PROPN
dpc-221	100	14	.	.	PUNCT
dpc-221	100	15	randomized	randomize	VERB
dpc-221	100	16	double	double	ADJ
dpc-221	100	17	-	-	PUNCT
dpc-221	100	18	blind	blind	ADJ
dpc-221	100	19	trial	trial	NOUN
dpc-221	100	20	of	of	ADP
dpc-221	100	21	treatment	treatment	NOUN
dpc-221	100	22	of	of	ADP
dpc-221	100	23	vitiligo	vitiligo	NOUN
dpc-221	100	24	:	:	PUNCT
dpc-221	100	25	efficacy	efficacy	NOUN
dpc-221	100	26	of	of	ADP
dpc-221	100	27	psoralenuv	psoralenuv	PROPN
dpc-221	100	28	-	-	PUNCT
dpc-221	100	29	a	a	DET
dpc-221	100	30	therapy	therapy	NOUN
dpc-221	100	31	versus	versus	ADP
dpc-221	100	32	narrowband	narrowband	NOUN
dpc-221	100	33	-	-	PUNCT
dpc-221	100	34	uv	uv	NOUN
dpc-221	100	35	-	-	PUNCT
dpc-221	100	36	b	b	NOUN
dpc-221	100	37	therapy	therapy	NOUN
dpc-221	100	38	.	.	PUNCT
dpc-221	101	1	arch	arch	ADJ
dpc-221	101	2	dermatol	dermatol	NOUN
dpc-221	101	3	.	.	PUNCT
dpc-221	102	1	2007;143(5	2007;143(5	NUM
dpc-221	102	2	):	):	PUNCT
dpc-221	102	3	578	578	NUM
dpc-221	102	4	-	-	SYM
dpc-221	102	5	584	584	NUM
dpc-221	102	6	.	.	NOUN
dpc-221	102	7	10	10	NUM
dpc-221	102	8	.	.	PUNCT
dpc-221	103	1	gupta	gupta	PROPN
dpc-221	103	2	d	d	PROPN
dpc-221	103	3	,	,	PUNCT
dpc-221	103	4	kumari	kumari	PROPN
dpc-221	103	5	r	r	PROPN
dpc-221	103	6	,	,	PUNCT
dpc-221	103	7	thappa	thappa	PROPN
dpc-221	103	8	dm	dm	PROPN
dpc-221	103	9	.	.	PUNCT
dpc-221	103	10	depigmentation	depigmentation	NOUN
dpc-221	103	11	therapies	therapy	NOUN
dpc-221	103	12	in	in	ADP
dpc-221	103	13	vitiligo	vitiligo	PROPN
dpc-221	103	14	.	.	PUNCT
dpc-221	104	1	indian	indian	PROPN
dpc-221	104	2	j	j	PROPN
dpc-221	104	3	dermatol	dermatol	PROPN
dpc-221	104	4	venereol	venereol	ADJ
dpc-221	104	5	leprol	leprol	NOUN
dpc-221	104	6	.	.	PUNCT
dpc-221	105	1	2012;78:49	2012;78:49	NUM
dpc-221	105	2	-	-	SYM
dpc-221	105	3	58	58	NUM
dpc-221	105	4	.	.	PUNCT
dpc-221	106	1	11	11	NUM
dpc-221	106	2	.	.	PUNCT
dpc-221	107	1	ransom	ransom	NOUN
dpc-221	107	2	jt	jt	PROPN
dpc-221	107	3	.	.	PUNCT
dpc-221	108	1	mechanism	mechanism	NOUN
dpc-221	108	2	of	of	ADP
dpc-221	108	3	action	action	NOUN
dpc-221	108	4	of	of	ADP
dpc-221	108	5	mycophenolate	mycophenolate	PROPN
dpc-221	108	6	mofetil	mofetil	PROPN
dpc-221	108	7	.	.	PUNCT
dpc-221	109	1	ther	ther	PROPN
dpc-221	109	2	drug	drug	PROPN
dpc-221	109	3	monit	monit	NOUN
dpc-221	109	4	.	.	PUNCT
dpc-221	110	1	1995;17(6):681	1995;17(6):681	PROPN
dpc-221	110	2	-	-	NUM
dpc-221	110	3	684	684	NUM
dpc-221	110	4	.	.	PUNCT
dpc-221	111	1	12	12	NUM
dpc-221	111	2	.	.	PUNCT
dpc-221	111	3	chapuis	chapuis	PROPN
dpc-221	111	4	ag	ag	PROPN
dpc-221	111	5	,	,	PUNCT
dpc-221	111	6	paolo	paolo	NOUN
dpc-221	111	7	rizzardi	rizzardi	NOUN
dpc-221	111	8	g	g	PROPN
dpc-221	111	9	,	,	PUNCT
dpc-221	111	10	d’agostino	d’agostino	NOUN
dpc-221	111	11	c	c	NOUN
dpc-221	111	12	,	,	PUNCT
dpc-221	111	13	et	et	PROPN
dpc-221	111	14	al	al	PROPN
dpc-221	111	15	.	.	PUNCT
dpc-221	112	1	effects	effect	NOUN
dpc-221	112	2	of	of	ADP
dpc-221	112	3	mycophenolic	mycophenolic	ADJ
dpc-221	112	4	acid	acid	NOUN
dpc-221	112	5	on	on	ADP
dpc-221	112	6	human	human	ADJ
dpc-221	112	7	immunodeficiency	immunodeficiency	NOUN
dpc-221	112	8	virus	virus	NOUN
dpc-221	112	9	infection	infection	NOUN
dpc-221	112	10	in	in	ADP
dpc-221	112	11	vitro	vitro	X
dpc-221	112	12	and	and	CCONJ
dpc-221	112	13	in	in	ADP
dpc-221	112	14	vivo	vivo	NOUN
dpc-221	112	15	.	.	PUNCT
dpc-221	113	1	nat	nat	PROPN
dpc-221	113	2	med	med	PROPN
dpc-221	113	3	.	.	PUNCT
dpc-221	114	1	2000;6(7):762	2000;6(7):762	NUM
dpc-221	114	2	-	-	SYM
dpc-221	114	3	768	768	NUM
dpc-221	114	4	.	.	PUNCT
dpc-221	115	1	13	13	NUM
dpc-221	115	2	.	.	PUNCT
dpc-221	116	1	lee	lee	PROPN
dpc-221	116	2	yf	yf	PROPN
dpc-221	116	3	,	,	PUNCT
dpc-221	116	4	cheng	cheng	PROPN
dpc-221	116	5	cc	cc	PROPN
dpc-221	116	6	,	,	PUNCT
dpc-221	116	7	lan	lan	PROPN
dpc-221	116	8	jl	jl	PROPN
dpc-221	116	9	,	,	PUNCT
dpc-221	116	10	et	et	PROPN
dpc-221	116	11	al	al	PROPN
dpc-221	116	12	.	.	PUNCT
dpc-221	116	13	effects	effect	NOUN
dpc-221	116	14	of	of	ADP
dpc-221	116	15	mycophenolate	mycophenolate	ADJ
dpc-221	116	16	mofetil	mofetil	NOUN
dpc-221	116	17	on	on	ADP
dpc-221	116	18	cutaneous	cutaneous	ADJ
dpc-221	116	19	lupus	lupus	NOUN
dpc-221	116	20	erythematosus	erythematosus	NOUN
dpc-221	116	21	in	in	ADP
dpc-221	116	22	(	(	PUNCT
dpc-221	116	23	nzb	nzb	PROPN
dpc-221	116	24	×	×	PROPN
dpc-221	116	25	nzw	nzw	PROPN
dpc-221	116	26	)	)	PUNCT
dpc-221	116	27	f1	f1	NOUN
dpc-221	116	28	mice	mouse	NOUN
dpc-221	116	29	.	.	PUNCT
dpc-221	117	1	j	j	PROPN
dpc-221	117	2	chin	chin	PROPN
dpc-221	117	3	med	med	PROPN
dpc-221	117	4	assoc	assoc	PROPN
dpc-221	117	5	.	.	PUNCT
dpc-221	118	1	2013;76(11):615	2013;76(11):615	NUM
dpc-221	118	2	-	-	SYM
dpc-221	118	3	623	623	NUM
dpc-221	118	4	.	.	PUNCT
dpc-221	119	1	14	14	NUM
dpc-221	119	2	.	.	PUNCT
dpc-221	120	1	wohlrab	wohlrab	PROPN
dpc-221	120	2	j	j	PROPN
dpc-221	120	3	,	,	PUNCT
dpc-221	120	4	jahn	jahn	PROPN
dpc-221	120	5	k	k	PROPN
dpc-221	120	6	,	,	PUNCT
dpc-221	120	7	plaetzer	plaetzer	NOUN
dpc-221	120	8	m	m	PROPN
dpc-221	120	9	,	,	PUNCT
dpc-221	120	10	neubert	neubert	ADJ
dpc-221	120	11	r	r	NOUN
dpc-221	120	12	,	,	PUNCT
dpc-221	120	13	marsch	marsch	PROPN
dpc-221	120	14	wc	wc	PROPN
dpc-221	120	15	.	.	PROPN
dpc-221	120	16	topical	topical	ADJ
dpc-221	120	17	application	application	NOUN
dpc-221	120	18	of	of	ADP
dpc-221	120	19	mycophenolate	mycophenolate	ADJ
dpc-221	120	20	mofetil	mofetil	NOUN
dpc-221	120	21	in	in	ADP
dpc-221	120	22	plaque	plaque	NOUN
dpc-221	120	23	-	-	PUNCT
dpc-221	120	24	type	type	NOUN
dpc-221	120	25	psoriasis	psoriasis	NOUN
dpc-221	120	26	.	.	PUNCT
dpc-221	121	1	br	br	PROPN
dpc-221	121	2	j	j	PROPN
dpc-221	121	3	dermatol	dermatol	NOUN
dpc-221	121	4	.	.	PUNCT
dpc-221	122	1	2001;144(6):1263	2001;144(6):1263	NUM
dpc-221	122	2	-	-	SYM
dpc-221	122	3	1264	1264	NUM
dpc-221	122	4	.	.	PUNCT
dpc-221	123	1	15	15	NUM
dpc-221	123	2	.	.	X
dpc-221	123	3	amnuaikit	amnuaikit	PROPN
dpc-221	123	4	t	t	PROPN
dpc-221	123	5	,	,	PUNCT
dpc-221	123	6	songkram	songkram	PROPN
dpc-221	123	7	c	c	PROPN
dpc-221	123	8	,	,	PUNCT
dpc-221	123	9	pinsuwan	pinsuwan	PROPN
dpc-221	123	10	s.	s.	PROPN
dpc-221	123	11	enhancement	enhancement	NOUN
dpc-221	123	12	of	of	ADP
dpc-221	123	13	mycophenolate	mycophenolate	PROPN
dpc-221	123	14	mofetil	mofetil	PROPN
dpc-221	123	15	permeation	permeation	NOUN
dpc-221	123	16	for	for	ADP
dpc-221	123	17	topical	topical	ADJ
dpc-221	123	18	use	use	NOUN
dpc-221	123	19	by	by	ADP
dpc-221	123	20	eucalyptol	eucalyptol	NOUN
dpc-221	123	21	and	and	CCONJ
dpc-221	123	22	n	n	CCONJ
dpc-221	123	23	-	-	PUNCT
dpc-221	123	24	methyl-2	methyl-2	NOUN
dpc-221	123	25	-	-	NOUN
dpc-221	123	26	pyrrolidone	pyrrolidone	NOUN
dpc-221	123	27	.	.	PUNCT
dpc-221	124	1	scientifica	scientifica	PROPN
dpc-221	124	2	(	(	PUNCT
dpc-221	124	3	cairo	cairo	PROPN
dpc-221	124	4	)	)	PUNCT
dpc-221	124	5	.	.	PUNCT
dpc-221	125	1	2016;2016:9672718	2016;2016:9672718	NUM
dpc-221	125	2	.	.	PUNCT
dpc-221	125	3	autoimmune	autoimmune	ADJ
dpc-221	125	4	destruction	destruction	NOUN
dpc-221	125	5	of	of	ADP
dpc-221	125	6	melanocytes	melanocyte	NOUN
dpc-221	125	7	is	be	AUX
dpc-221	125	8	currently	currently	ADV
dpc-221	125	9	the	the	DET
dpc-221	125	10	leading	lead	VERB
dpc-221	125	11	hypothesis	hypothesis	NOUN
dpc-221	125	12	in	in	ADP
dpc-221	125	13	vitiligo	vitiligo	NOUN
dpc-221	125	14	pathogenesis	pathogenesis	NOUN
dpc-221	125	15	.	.	PUNCT
dpc-221	126	1	the	the	DET
dpc-221	126	2	immune	immune	ADJ
dpc-221	126	3	system	system	NOUN
dpc-221	126	4	involved	involve	VERB
dpc-221	126	5	in	in	ADP
dpc-221	126	6	this	this	DET
dpc-221	126	7	destruction	destruction	NOUN
dpc-221	126	8	includes	include	VERB
dpc-221	126	9	the	the	DET
dpc-221	126	10	cellular	cellular	ADJ
dpc-221	126	11	and	and	CCONJ
dpc-221	126	12	humoral	humoral	ADJ
dpc-221	126	13	immunity	immunity	NOUN
dpc-221	126	14	and	and	CCONJ
dpc-221	126	15	various	various	ADJ
dpc-221	126	16	cytokines	cytokine	NOUN
dpc-221	126	17	.	.	PUNCT
dpc-221	127	1	the	the	DET
dpc-221	127	2	presence	presence	NOUN
dpc-221	127	3	of	of	ADP
dpc-221	127	4	several	several	ADJ
dpc-221	127	5	antibodies	antibody	NOUN
dpc-221	127	6	against	against	ADP
dpc-221	127	7	different	different	ADJ
dpc-221	127	8	melanocyte	melanocyte	NOUN
dpc-221	127	9	-	-	PUNCT
dpc-221	127	10	associated	associate	VERB
dpc-221	127	11	antigens	antigen	NOUN
dpc-221	127	12	was	be	AUX
dpc-221	127	13	confirmed	confirm	VERB
dpc-221	127	14	in	in	ADP
dpc-221	127	15	vitiligo	vitiligo	PROPN
dpc-221	127	16	.	.	PUNCT
dpc-221	128	1	elimination	elimination	NOUN
dpc-221	128	2	of	of	ADP
dpc-221	128	3	melanocytes	melanocyte	NOUN
dpc-221	128	4	by	by	ADP
dpc-221	128	5	cytotoxic	cytotoxic	ADJ
dpc-221	128	6	t	t	NOUN
dpc-221	128	7	cells	cell	NOUN
dpc-221	128	8	is	be	AUX
dpc-221	128	9	also	also	ADV
dpc-221	128	10	another	another	DET
dpc-221	128	11	mechanism	mechanism	NOUN
dpc-221	128	12	involved	involve	VERB
dpc-221	128	13	in	in	ADP
dpc-221	128	14	vitiligo	vitiligo	NOUN
dpc-221	128	15	.	.	PUNCT
dpc-221	129	1	cytokines	cytokine	NOUN
dpc-221	129	2	also	also	ADV
dpc-221	129	3	play	play	VERB
dpc-221	129	4	an	an	DET
dpc-221	129	5	important	important	ADJ
dpc-221	129	6	role	role	NOUN
dpc-221	129	7	in	in	ADP
dpc-221	129	8	vitiligo	vitiligo	PROPN
dpc-221	129	9	.	.	PUNCT
dpc-221	130	1	increased	increase	VERB
dpc-221	130	2	levels	level	NOUN
dpc-221	130	3	of	of	ADP
dpc-221	130	4	tumor	tumor	NOUN
dpc-221	130	5	necrosis	necrosis	NOUN
dpc-221	130	6	alpha	alpha	NOUN
dpc-221	130	7	(	(	PUNCT
dpc-221	130	8	tnf	tnf	PROPN
dpc-221	130	9	-	-	PUNCT
dpc-221	130	10	α	α	NOUN
dpc-221	130	11	)	)	PUNCT
dpc-221	130	12	and	and	CCONJ
dpc-221	130	13	interferon	interferon	ADJ
dpc-221	130	14	-	-	PUNCT
dpc-221	130	15	gamma	gamma	NOUN
dpc-221	130	16	(	(	PUNCT
dpc-221	130	17	ifn	ifn	PROPN
dpc-221	130	18	-	-	PUNCT
dpc-221	130	19	γ	γ	NOUN
dpc-221	130	20	)	)	PUNCT
dpc-221	130	21	are	be	AUX
dpc-221	130	22	important	important	ADJ
dpc-221	130	23	arms	arm	NOUN
dpc-221	130	24	in	in	ADP
dpc-221	130	25	vitiligo	vitiligo	ADJ
dpc-221	130	26	pathogenesis	pathogenesis	NOUN
dpc-221	130	27	[	[	X
dpc-221	130	28	5	5	NUM
dpc-221	130	29	]	]	PUNCT
dpc-221	130	30	.	.	PUNCT
dpc-221	131	1	mmf	mmf	NOUN
dpc-221	131	2	inhibits	inhibit	VERB
dpc-221	131	3	dna	dna	PROPN
dpc-221	131	4	synthesis	synthesis	NOUN
dpc-221	131	5	in	in	ADP
dpc-221	131	6	lymphocytes	lymphocyte	NOUN
dpc-221	131	7	,	,	PUNCT
dpc-221	131	8	and	and	CCONJ
dpc-221	131	9	inhibits	inhibit	VERB
dpc-221	131	10	the	the	DET
dpc-221	131	11	production	production	NOUN
dpc-221	131	12	of	of	ADP
dpc-221	131	13	antibody	antibody	NOUN
dpc-221	131	14	by	by	ADP
dpc-221	131	15	b	b	NOUN
dpc-221	131	16	-	-	PUNCT
dpc-221	131	17	cells	cell	NOUN
dpc-221	131	18	.	.	PUNCT
dpc-221	132	1	the	the	DET
dpc-221	132	2	drug	drug	NOUN
dpc-221	132	3	prevents	prevent	VERB
dpc-221	132	4	glycosylation	glycosylation	NOUN
dpc-221	132	5	and	and	CCONJ
dpc-221	132	6	expression	expression	NOUN
dpc-221	132	7	of	of	ADP
dpc-221	132	8	binding	bind	VERB
dpc-221	132	9	molecules	molecule	NOUN
dpc-221	132	10	and	and	CCONJ
dpc-221	132	11	the	the	DET
dpc-221	132	12	infiltration	infiltration	NOUN
dpc-221	132	13	of	of	ADP
dpc-221	132	14	lymphocytes	lymphocyte	NOUN
dpc-221	132	15	and	and	CCONJ
dpc-221	132	16	monocytes	monocyte	VERB
dpc-221	132	17	into	into	ADP
dpc-221	132	18	sites	site	NOUN
dpc-221	132	19	of	of	ADP
dpc-221	132	20	inflammation	inflammation	NOUN
dpc-221	132	21	[	[	X
dpc-221	132	22	11	11	NUM
dpc-221	132	23	]	]	PUNCT
dpc-221	132	24	.	.	PUNCT
dpc-221	133	1	in	in	ADP
dpc-221	133	2	this	this	DET
dpc-221	133	3	study	study	NOUN
dpc-221	133	4	,	,	PUNCT
dpc-221	133	5	the	the	DET
dpc-221	133	6	maximum	maximum	ADJ
dpc-221	133	7	concentration	concentration	NOUN
dpc-221	133	8	of	of	ADP
dpc-221	133	9	topical	topical	ADJ
dpc-221	133	10	mmf	mmf	NOUN
dpc-221	133	11	,	,	PUNCT
dpc-221	133	12	using	use	VERB
dpc-221	133	13	its	its	PRON
dpc-221	133	14	500	500	NUM
dpc-221	133	15	mg	mg	PROPN
dpc-221	133	16	tablet	tablet	NOUN
dpc-221	133	17	,	,	PUNCT
dpc-221	133	18	was	be	AUX
dpc-221	133	19	utilized	utilize	VERB
dpc-221	133	20	.	.	PUNCT
dpc-221	134	1	at	at	ADP
dpc-221	134	2	the	the	DET
dpc-221	134	3	end	end	NOUN
dpc-221	134	4	of	of	ADP
dpc-221	134	5	first	first	ADJ
dpc-221	134	6	month	month	NOUN
dpc-221	134	7	,	,	PUNCT
dpc-221	134	8	only	only	ADV
dpc-221	134	9	one	one	NUM
dpc-221	134	10	patient	patient	NOUN
dpc-221	134	11	had	have	VERB
dpc-221	134	12	dramatic	dramatic	ADJ
dpc-221	134	13	response	response	NOUN
dpc-221	134	14	with	with	ADP
dpc-221	134	15	40	40	NUM
dpc-221	134	16	%	%	NOUN
dpc-221	134	17	repigmentation	repigmentation	NOUN
dpc-221	134	18	,	,	PUNCT
dpc-221	134	19	but	but	CCONJ
dpc-221	134	20	at	at	ADP
dpc-221	134	21	the	the	DET
dpc-221	134	22	end	end	NOUN
dpc-221	134	23	of	of	ADP
dpc-221	134	24	second	second	ADJ
dpc-221	134	25	month	month	NOUN
dpc-221	134	26	16.6	16.6	NUM
dpc-221	134	27	%	%	NOUN
dpc-221	134	28	of	of	ADP
dpc-221	134	29	the	the	DET
dpc-221	134	30	patients	patient	NOUN
dpc-221	134	31	had	have	AUX
dpc-221	134	32	achieved	achieve	VERB
dpc-221	134	33	25	25	NUM
dpc-221	134	34	%	%	NOUN
dpc-221	134	35	repigmentation	repigmentation	NOUN
dpc-221	134	36	,	,	PUNCT
dpc-221	134	37	and	and	CCONJ
dpc-221	134	38	in	in	ADP
dpc-221	134	39	the	the	DET
dpc-221	134	40	third	third	ADJ
dpc-221	134	41	month	month	NOUN
dpc-221	134	42	,	,	PUNCT
dpc-221	134	43	36.6	36.6	NUM
dpc-221	134	44	%	%	NOUN
dpc-221	134	45	of	of	ADP
dpc-221	134	46	patients	patient	NOUN
dpc-221	134	47	achieved	achieve	VERB
dpc-221	134	48	25	25	NUM
dpc-221	134	49	%	%	NOUN
dpc-221	134	50	repigmentation	repigmentation	NOUN
dpc-221	134	51	.	.	PUNCT
dpc-221	135	1	this	this	DET
dpc-221	135	2	study	study	NOUN
dpc-221	135	3	showed	show	VERB
dpc-221	135	4	that	that	DET
dpc-221	135	5	mmf	mmf	NOUN
dpc-221	135	6	may	may	AUX
dpc-221	135	7	be	be	AUX
dpc-221	135	8	an	an	DET
dpc-221	135	9	alternative	alternative	ADJ
dpc-221	135	10	and	and	CCONJ
dpc-221	135	11	safe	safe	ADJ
dpc-221	135	12	topical	topical	ADJ
dpc-221	135	13	drug	drug	NOUN
dpc-221	135	14	therapy	therapy	NOUN
dpc-221	135	15	for	for	ADP
dpc-221	135	16	vitiligo	vitiligo	NOUN
dpc-221	135	17	.	.	PUNCT
dpc-221	136	1	topical	topical	ADJ
dpc-221	136	2	mmf	mmf	NOUN
dpc-221	136	3	is	be	AUX
dpc-221	136	4	also	also	ADV
dpc-221	136	5	used	use	VERB
dpc-221	136	6	in	in	ADP
dpc-221	136	7	plaque	plaque	NOUN
dpc-221	136	8	type	type	NOUN
dpc-221	136	9	psoriasis	psoriasis	NOUN
dpc-221	136	10	with	with	ADP
dpc-221	136	11	success	success	NOUN
dpc-221	136	12	.	.	PUNCT
dpc-221	137	1	pure	pure	ADJ
dpc-221	137	2	mmf	mmf	NOUN
dpc-221	137	3	2	2	NUM
dpc-221	137	4	%	%	NOUN
dpc-221	137	5	was	be	AUX
dpc-221	137	6	compared	compare	VERB
dpc-221	137	7	to	to	ADP
dpc-221	137	8	0.1	0.1	NUM
dpc-221	137	9	%	%	NOUN
dpc-221	137	10	betamethasone-17	betamethasone-17	NOUN
dpc-221	137	11	-	-	PUNCT
dpc-221	137	12	valerate	valerate	ADJ
dpc-221	137	13	cream	cream	NOUN
dpc-221	137	14	.	.	PUNCT
dpc-221	138	1	no	no	DET
dpc-221	138	2	difference	difference	NOUN
dpc-221	138	3	was	be	AUX
dpc-221	138	4	seen	see	VERB
dpc-221	138	5	between	between	ADP
dpc-221	138	6	the	the	DET
dpc-221	138	7	therapeutic	therapeutic	ADJ
dpc-221	138	8	efficacies	efficacy	NOUN
dpc-221	138	9	of	of	ADP
dpc-221	138	10	both	both	DET
dpc-221	138	11	topical	topical	ADJ
dpc-221	138	12	drugs	drug	NOUN
dpc-221	138	13	in	in	ADP
dpc-221	138	14	psoriasis	psoriasis	NOUN
dpc-221	138	15	[	[	X
dpc-221	138	16	14	14	NUM
dpc-221	138	17	]	]	PUNCT
dpc-221	138	18	.	.	PUNCT
dpc-221	139	1	nearly	nearly	ADV
dpc-221	139	2	all	all	DET
dpc-221	139	3	the	the	DET
dpc-221	139	4	lesions	lesion	NOUN
dpc-221	139	5	that	that	PRON
dpc-221	139	6	showed	show	VERB
dpc-221	139	7	a	a	DET
dpc-221	139	8	good	good	ADJ
dpc-221	139	9	response	response	NOUN
dpc-221	139	10	to	to	ADP
dpc-221	139	11	mmf	mmf	NOUN
dpc-221	139	12	therapy	therapy	NOUN
dpc-221	139	13	were	be	AUX
dpc-221	139	14	in	in	ADP
dpc-221	139	15	sun	sun	NOUN
dpc-221	139	16	-	-	PUNCT
dpc-221	139	17	exposed	expose	VERB
dpc-221	139	18	areas	area	NOUN
dpc-221	139	19	;	;	PUNCT
dpc-221	139	20	this	this	PRON
dpc-221	139	21	may	may	AUX
dpc-221	139	22	be	be	AUX
dpc-221	139	23	due	due	ADJ
dpc-221	139	24	to	to	ADP
dpc-221	139	25	the	the	DET
dpc-221	139	26	synergistic	synergistic	ADJ
dpc-221	139	27	effects	effect	NOUN
dpc-221	139	28	of	of	ADP
dpc-221	139	29	natural	natural	ADJ
dpc-221	139	30	ultraviolet	ultraviolet	ADJ
dpc-221	139	31	light	light	NOUN
dpc-221	139	32	in	in	ADP
dpc-221	139	33	the	the	DET
dpc-221	139	34	repigmentation	repigmentation	NOUN
dpc-221	139	35	of	of	ADP
dpc-221	139	36	vitiligo	vitiligo	ADJ
dpc-221	139	37	lesions	lesion	NOUN
dpc-221	139	38	.	.	PUNCT
dpc-221	140	1	there	there	PRON
dpc-221	140	2	are	be	VERB
dpc-221	140	3	some	some	DET
dpc-221	140	4	limitations	limitation	NOUN
dpc-221	140	5	in	in	ADP
dpc-221	140	6	this	this	DET
dpc-221	140	7	study	study	NOUN
dpc-221	140	8	.	.	PUNCT
dpc-221	141	1	firstly	firstly	ADV
dpc-221	141	2	,	,	PUNCT
dpc-221	141	3	because	because	SCONJ
dpc-221	141	4	it	it	PRON
dpc-221	141	5	was	be	AUX
dpc-221	141	6	a	a	DET
dpc-221	141	7	pilot	pilot	NOUN
dpc-221	141	8	study	study	NOUN
dpc-221	141	9	,	,	PUNCT
dpc-221	141	10	the	the	DET
dpc-221	141	11	number	number	NOUN
dpc-221	141	12	of	of	ADP
dpc-221	141	13	cases	case	NOUN
dpc-221	141	14	was	be	AUX
dpc-221	141	15	few	few	ADJ
dpc-221	141	16	and	and	CCONJ
dpc-221	141	17	there	there	PRON
dpc-221	141	18	was	be	VERB
dpc-221	141	19	no	no	DET
dpc-221	141	20	control	control	NOUN
dpc-221	141	21	group	group	NOUN
dpc-221	141	22	.	.	PUNCT
dpc-221	142	1	further	further	ADJ
dpc-221	142	2	studies	study	NOUN
dpc-221	142	3	with	with	ADP
dpc-221	142	4	larger	large	ADJ
dpc-221	142	5	sample	sample	NOUN
dpc-221	142	6	sizes	size	NOUN
dpc-221	142	7	and	and	CCONJ
dpc-221	142	8	in	in	ADP
dpc-221	142	9	the	the	DET
dpc-221	142	10	form	form	NOUN
dpc-221	142	11	of	of	ADP
dpc-221	142	12	randomized	randomized	ADJ
dpc-221	142	13	clinical	clinical	ADJ
dpc-221	142	14	trials	trial	NOUN
dpc-221	142	15	are	be	AUX
dpc-221	142	16	needed	need	VERB
dpc-221	142	17	to	to	PART
dpc-221	142	18	assess	assess	VERB
dpc-221	142	19	the	the	DET
dpc-221	142	20	efficacy	efficacy	NOUN
dpc-221	142	21	of	of	ADP
dpc-221	142	22	topical	topical	ADJ
dpc-221	142	23	mmf	mmf	NOUN
dpc-221	142	24	in	in	ADP
dpc-221	142	25	the	the	DET
dpc-221	142	26	treatment	treatment	NOUN
dpc-221	142	27	of	of	ADP
dpc-221	142	28	vitiligo	vitiligo	NOUN
dpc-221	142	29	.	.	PUNCT
dpc-221	143	1	secondly	secondly	ADV
dpc-221	143	2	,	,	PUNCT
dpc-221	143	3	because	because	SCONJ
dpc-221	143	4	of	of	ADP
dpc-221	143	5	the	the	DET
dpc-221	143	6	difficulty	difficulty	NOUN
dpc-221	143	7	in	in	ADP
dpc-221	143	8	skin	skin	NOUN
dpc-221	143	9	penetration	penetration	NOUN
dpc-221	143	10	of	of	ADP
dpc-221	143	11	topical	topical	ADJ
dpc-221	143	12	drugs	drug	NOUN
dpc-221	143	13	,	,	PUNCT
dpc-221	143	14	using	use	VERB
dpc-221	143	15	skin	skin	NOUN
dpc-221	143	16	permeation	permeation	NOUN
dpc-221	143	17	enhancers	enhancer	NOUN
dpc-221	143	18	,	,	PUNCT
dpc-221	143	19	such	such	ADJ
dpc-221	143	20	as	as	ADP
dpc-221	143	21	eucalyptol	eucalyptol	NOUN
dpc-221	143	22	(	(	PUNCT
dpc-221	143	23	eul	eul	NOUN
dpc-221	143	24	)	)	PUNCT
dpc-221	143	25	and	and	CCONJ
dpc-221	143	26	n	n	CCONJ
dpc-221	143	27	-	-	PUNCT
dpc-221	143	28	methyl-2	methyl-2	NOUN
dpc-221	143	29	-	-	NOUN
dpc-221	143	30	pyrrolidone	pyrrolidone	NOUN
dpc-221	143	31	(	(	PUNCT
dpc-221	143	32	nmp	nmp	PROPN
dpc-221	143	33	)	)	PUNCT
dpc-221	143	34	suggested	suggest	VERB
dpc-221	143	35	by	by	ADP
dpc-221	143	36	amnuaikit	amnuaikit	NOUN
dpc-221	143	37	et	et	NOUN
dpc-221	143	38	al	al	PROPN
dpc-221	143	39	may	may	AUX
dpc-221	143	40	increase	increase	VERB
dpc-221	143	41	the	the	DET
dpc-221	143	42	therapeutic	therapeutic	ADJ
dpc-221	143	43	efficacy	efficacy	NOUN
dpc-221	143	44	of	of	ADP
dpc-221	143	45	topical	topical	ADJ
dpc-221	143	46	mmf	mmf	NOUN
dpc-221	144	1	[	[	X
dpc-221	144	2	15	15	NUM
dpc-221	144	3	]	]	PUNCT
dpc-221	144	4	.	.	PUNCT
dpc-221	145	1	table	table	NOUN
dpc-221	145	2	1	1	NUM
dpc-221	145	3	.	.	PUNCT
dpc-221	145	4	overall	overall	ADJ
dpc-221	145	5	pigmentation	pigmentation	NOUN
dpc-221	145	6	at	at	ADP
dpc-221	145	7	the	the	DET
dpc-221	145	8	end	end	NOUN
dpc-221	145	9	of	of	ADP
dpc-221	145	10	each	each	DET
dpc-221	145	11	month	month	NOUN
dpc-221	145	12	with	with	ADP
dpc-221	145	13	mmf	mmf	NOUN
dpc-221	145	14	therapy	therapy	NOUN
dpc-221	145	15	.	.	PUNCT
dpc-221	146	1	[	[	X
dpc-221	146	2	copyright	copyright	NOUN
dpc-221	146	3	:	:	PUNCT
dpc-221	146	4	©	©	PROPN
dpc-221	146	5	2017	2017	NUM
dpc-221	146	6	handjani	handjani	X
dpc-221	146	7	et	et	PROPN
dpc-221	146	8	al	al	PROPN
dpc-221	146	9	.	.	PROPN
dpc-221	146	10	]	]	PUNCT
dpc-221	146	11	time	time	NOUN
dpc-221	146	12	(	(	PUNCT
dpc-221	146	13	at	at	ADP
dpc-221	146	14	the	the	DET
dpc-221	146	15	end	end	NOUN
dpc-221	146	16	of	of	ADP
dpc-221	146	17	each	each	DET
dpc-221	146	18	month	month	NOUN
dpc-221	146	19	)	)	PUNCT
dpc-221	146	20	pigmentation	pigmentation	NOUN
dpc-221	146	21	(	(	PUNCT
dpc-221	146	22	mean	mean	VERB
dpc-221	146	23	+	+	PROPN
dpc-221	146	24	/sd	/sd	NOUN
dpc-221	146	25	)	)	PUNCT
dpc-221	146	26	1st	1st	ADJ
dpc-221	146	27	month	month	NOUN
dpc-221	146	28	1.33+/1.33	1.33+/1.33	NUM
dpc-221	146	29	2nd	2nd	ADJ
dpc-221	146	30	month	month	NOUN
dpc-221	146	31	4.16+/2.19	4.16+/2.19	NOUN
dpc-221	146	32	3rd	3rd	ADJ
dpc-221	146	33	month	month	NOUN
dpc-221	146	34	10	10	NUM
dpc-221	146	35	+	+	NOUN
dpc-221	146	36	/2.82	/2.82	PUNCT